var title_f35_10_36000="Gentamicin: Drug information";
var content_f35_10_36000=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Gentamicin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12618257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/21/3412?source=see_link\">",
"       Gentamicin (ophthalmic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/47/761?source=see_link\">",
"       Gentamicin (systemic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/46/17123?source=see_link\">",
"       Gentamicin (topical): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8489 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-59F4F6E9F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36000=[""].join("\n");
var outline_f35_10_36000=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?3/21/3412?source=related_link\">",
"      Gentamicin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?0/47/761?source=related_link\">",
"      Gentamicin (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/46/17123?source=related_link\">",
"      Gentamicin (topical): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_10_36001="Cochlear histology";
var content_f35_10_36001=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cochlear embryology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 326px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This axial histologic section of the temporal bone at 9 weeks gestation demonstrates the rudimentary vestiblule (v) and cochlea (c), with only one turn.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36001=[""].join("\n");
var outline_f35_10_36001=null;
var title_f35_10_36002="Patient information: Thyroid cancer (The Basics)";
var content_f35_10_36002=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/82979\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/43/15024\">",
"         Thyroid and parathyroid glands",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?1/40/1667\">",
"         Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?0/36/579\">",
"         Patient information: Managing pain when you have cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?25/21/25939\">",
"         Patient information: Medical care during advanced illness (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/32/40450\">",
"         Patient information: Radiation therapy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?23/4/23618\">",
"         Patient information: Thyroid nodules (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?18/16/18691\">",
"         Patient information: Thyroid nodules (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Thyroid cancer (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/thyroid-cancer-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H13414417\">",
"      <span class=\"h1\">",
"       What is thyroid cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Thyroid cancer happens when normal cells in the thyroid change into abnormal cells and grow out of control. The thyroid is a gland in the middle of the neck (",
"      <a class=\"graphic graphic_figure graphicRef66834 \" href=\"mobipreview.htm?14/43/15024\">",
"       figure 1",
"      </a>",
"      ). The thyroid gland makes thyroid hormone.",
"     </p>",
"     <p>",
"      There are different types of thyroid cancer. Some types are more serious than others.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13414432\">",
"      <span class=\"h1\">",
"       What are the symptoms of thyroid cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Early on, people might not notice any symptoms. They might find out they have thyroid cancer after their doctor does an imaging test of their neck for another reason. Imaging tests create pictures of the inside of the body.",
"     </p>",
"     <p>",
"      When thyroid cancer causes symptoms, the most common symptom is a growth (called a &ldquo;nodule&rdquo;) on the thyroid gland. This growth usually gets bigger in a short amount of time. In some cases, people see or feel the growth themselves. In other cases, their doctor or nurse feels the growth during a routine exam.",
"     </p>",
"     <p>",
"      Other symptoms of thyroid cancer can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Hoarseness or being unable to talk",
"       </li>",
"       <li>",
"        Trouble breathing",
"       </li>",
"       <li>",
"        Trouble swallowing",
"       </li>",
"       <li>",
"        A cough or coughing up blood",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      All of these symptoms can also be caused by conditions that are not thyroid cancer. But if you have these symptoms, tell your doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13414447\">",
"      <span class=\"h1\">",
"       Is there a test for thyroid cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you have a growth on your thyroid gland, your doctor will do tests to see whether the growth is cancer or not. (Many growths on the thyroid gland are not cancer.) These tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Imaging tests &ndash; The imaging test most often done is an ultrasound, which uses sound waves to create pictures of the thyroid. Some people also have a thyroid scan. For a thyroid scan, a person gets a pill or shot with a small amount of a radioactive substance. Then a special camera takes a picture of the thyroid.",
"       </li>",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Fine needle aspiration &ndash; For this test, the doctor uses a thin needle to remove a small sample of tissue from the growth. Then another doctor looks at the tissue under a microscope.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13414462\">",
"      <span class=\"h1\">",
"       What is cancer staging?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cancer staging is a way in which doctors find out if a cancer has spread past the layer of tissue where it began, and, if so, how far.",
"     </p>",
"     <p>",
"      The right treatment for you will depend a lot on the type of thyroid cancer you have, its stage, and your other medical problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13414477\">",
"      <span class=\"h1\">",
"       How is thyroid cancer treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Thyroid cancer is usually treated with 1 or more of the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Surgery &ndash; In most cases, thyroid cancer is treated with surgery to remove the cancer. Your doctor will remove part or all of your thyroid gland. He or she might also remove nearby lymph nodes, which are bean-shaped organs that are part of the body&rsquo;s infection-fighting system.",
"       </li>",
"       <li>",
"        Radioactive iodine &ndash; Radioactive iodine (also called &ldquo;radioiodine therapy&rdquo;) comes in a pill or liquid that you swallow. It has a small amount of radiation and can destroy much of the thyroid gland.",
"       </li>",
"       <li>",
"        Thyroid hormone &ndash; Your doctor will prescribe thyroid hormone medicines after surgery or radioactive iodine treatment. That way, your body will have the correct amount of thyroid hormone.",
"       </li>",
"       <li>",
"        External-beam radiation therapy &ndash; This treatment uses high doses of X-rays, called radiation, to kill cancer cells. The radiation comes from a machine that is outside the body.",
"       </li>",
"       <li>",
"        Chemotherapy &ndash; Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13414492\">",
"      <span class=\"h1\">",
"       What happens after treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, your doctor will check you every so often to see if the cancer comes back. Regular follow-up tests include exams, blood tests, and imaging tests. Your doctor will also do regular follow-up blood tests to check your thyroid hormone levels.",
"     </p>",
"     <p>",
"      You should also watch for the symptoms listed above. Having those symptoms could mean your thyroid cancer has come back. Tell your doctor or nurse if you have any symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13414507\">",
"      <span class=\"h1\">",
"       What happens if my thyroid cancer comes back or spreads?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your thyroid cancer comes back or spreads, you might have more surgery, radioactive iodine treatment, external-beam radiation, or chemotherapy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13414522\">",
"      <span class=\"h1\">",
"       What else should I do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It&rsquo;s important to follow all your doctor&rsquo;s instructions about visits and tests. It&rsquo;s also important to talk to your doctor about any side effects or problems you have during treatment.",
"     </p>",
"     <p>",
"      Getting treated for thyroid cancer involves making many choices, such as what treatment to have. Always let your doctors and nurses know how you feel about a treatment. Any time you are offered a treatment, ask:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        What are the benefits of this treatment? Is it likely to help me live longer? Will it reduce or prevent symptoms?",
"       </li>",
"       <li>",
"        What are the downsides to this treatment?",
"       </li>",
"       <li>",
"        Are there other options besides this treatment?",
"       </li>",
"       <li>",
"        What happens if I do not have this treatment?",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H13414537\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/4/23618?source=see_link\">",
"       Patient information: Thyroid nodules (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/32/40450?source=see_link\">",
"       Patient information: Radiation therapy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?1/40/1667?source=see_link\">",
"       Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/36/579?source=see_link\">",
"       Patient information: Managing pain when you have cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/21/25939?source=see_link\">",
"       Patient information: Medical care during advanced illness (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/16/18691?source=see_link\">",
"       Patient information: Thyroid nodules (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?35/10/36002?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82979 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-AF7A4312D5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36002=[""].join("\n");
var outline_f35_10_36002=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414417\">",
"      What is thyroid cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414432\">",
"      What are the symptoms of thyroid cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414447\">",
"      Is there a test for thyroid cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414462\">",
"      What is cancer staging?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414477\">",
"      How is thyroid cancer treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414492\">",
"      What happens after treatment?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414507\">",
"      What happens if my thyroid cancer comes back or spreads?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414522\">",
"      What else should I do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13414537\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/82979\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/43/15024\">",
"      Thyroid and parathyroid glands",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?1/40/1667?source=related_link\">",
"      Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/36/579?source=related_link\">",
"      Patient information: Managing pain when you have cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/21/25939?source=related_link\">",
"      Patient information: Medical care during advanced illness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/32/40450?source=related_link\">",
"      Patient information: Radiation therapy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/16/18691?source=related_link\">",
"      Patient information: Thyroid nodules (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/4/23618?source=related_link\">",
"      Patient information: Thyroid nodules (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_10_36003="Confluent and reticulated papillomatosis - back";
var content_f35_10_36003=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Confluent and reticulated papillomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reticulated, hyperpigmented patches and thin plaques with fine scale are present on the upper back.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36003=[""].join("\n");
var outline_f35_10_36003=null;
var title_f35_10_36004="Lateral condyle fracture anatomy";
var content_f35_10_36004=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52534&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52534&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stages of displacement of a lateral condyle fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 598px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panels A and B: Stage 1 displacement - articular surface intact. Panels C and D: Stage II displacement - articular surface disrupted. Panels E and F: Stage III displacement - fragment rotated. (Panels A, C, and E: Reprinted from Jakob R, Fowles JV, Rang M, et al. Observations concerning fractures of the lateral humeral condyle in children.",
"    <em>",
"     J Bone Joint Surg [BR]",
"    </em>",
"    1975;57:430-436; with permission.)",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Beaty JH, Kasser JR. The elbow: Physeal fractures, apophyseal injuries of the distal humerus, avascular necrosis of the trochlea, and T-condylar fractures. In: Rockwood and Wilkins' Fractures in Children, 5th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams and Wilkins 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36004=[""].join("\n");
var outline_f35_10_36004=null;
var title_f35_10_36005="Doxycycline: Patient drug information";
var content_f35_10_36005=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Doxycycline: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"     see \"Doxycycline: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/54/12136?source=see_link\">",
"     see \"Doxycycline: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F163331\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Adoxa&reg;;",
"     </li>",
"     <li>",
"      Alodox&trade;;",
"     </li>",
"     <li>",
"      Doryx&reg;;",
"     </li>",
"     <li>",
"      Doxy 100&trade;;",
"     </li>",
"     <li>",
"      Monodox&reg;;",
"     </li>",
"     <li>",
"      Ocudox&trade;;",
"     </li>",
"     <li>",
"      Oracea&reg;;",
"     </li>",
"     <li>",
"      Oraxyl&trade;;",
"     </li>",
"     <li>",
"      Vibramycin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F163332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Doxy Tabs&reg;;",
"     </li>",
"     <li>",
"      Apo-Doxy&reg;;",
"     </li>",
"     <li>",
"      Dom-Doxycycline;",
"     </li>",
"     <li>",
"      Doxycin;",
"     </li>",
"     <li>",
"      Doxytab;",
"     </li>",
"     <li>",
"      Novo-Doxylin;",
"     </li>",
"     <li>",
"      Nu-Doxycycline;",
"     </li>",
"     <li>",
"      Periostat&reg;;",
"     </li>",
"     <li>",
"      PHL-Doxycycline;",
"     </li>",
"     <li>",
"      PMS-Doxycycline;",
"     </li>",
"     <li>",
"      Vibra-Tabs&reg;;",
"     </li>",
"     <li>",
"      Vibramycin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025586\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat pimples (acne).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691487",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat bacterial infections.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691703",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat swelling of the tissue around the teeth (periodontitis). It is used with scaling and root planing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Oracea&trade; is used to treat rosacea.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701986",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to doxycycline or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697143",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfite allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take bismuth (Pepto-Bismol&reg;), calcium, iron, magnesium, zinc, multivitamins with minerals, colestipol, cholestyramine, didanosine, or antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025593\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698339",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effects from Periostat&reg; are less.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025595\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Oracea&trade;: Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694319",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension, syrup) if you cannot swallow pills. Shake suspension well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Stop tube feeding for 2 hours before giving this drug. Restart tube feeding 1 hour after giving.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705565",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablets and capsules:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take tablets and capsules with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694812",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Doryx&reg;: You may sprinkle tablet contents in applesauce. Carefully break tablet without crushing pellets. Do not chew.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694729",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not lie down for at least 30 minutes after taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699444",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (suspension) at room temperature or in a refrigerator. Do not freeze. Throw away any part not used after 2 weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any unused part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to store the shot closely. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025597\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12402 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-AB43D6AFE1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36005=[""].join("\n");
var outline_f35_10_36005=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163331\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163332\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025586\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025588\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025587\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025592\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025593\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025595\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025590\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025591\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025596\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025597\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=related_link\">",
"      Doxycycline: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/54/12136?source=related_link\">",
"      Doxycycline: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_10_36006="Molecular diagnosis of central nervous system infections";
var content_f35_10_36006=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Molecular diagnosis of central nervous system infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36006/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36006/contributors\">",
"     Cathy A Petti, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36006/contributors\">",
"     Christopher R Polage, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36006/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36006/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36006/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36006/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/10/36006/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular diagnostic tests and nucleic acid amplification (NAA) tests are used synonymously in reference to test methods that detect deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) specific to infectious organisms (eg, bacteria, viruses) as a means of diagnosis. Such tests have dramatically impacted both the diagnosis and management of infectious diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36006/abstract/1\">",
"     1",
"    </a>",
"    ]. This is particularly true for central nervous system (CNS) infections where rapid, accurate identification of a pathogen and prompt initiation of antimicrobial therapy are potentially lifesaving.",
"   </p>",
"   <p>",
"    The increasing availability and use of molecular tests for the detection of microorganisms from cerebrospinal fluid (CSF) has redefined our approach to common CNS infections such as meningitis, encephalitis, and brain mass-lesions (particularly in HIV-infected individuals or other immunocompromised hosts), and improved our ability to identify the etiologic agent responsible for other CNS syndromes such as transverse myelitis.",
"   </p>",
"   <p>",
"    The unique aspects of molecular testing as applied to CNS infections and guidance in the use and interpretation of molecular testing for pathogens commonly encountered in the management of patients with CNS infections will be reviewed here. Management of specific CNS infections is discussed in the appropriate topics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/3/15417?source=see_link\">",
"     \"Aseptic meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/21/10586?source=see_link\">",
"     \"Viral meningitis: Clinical features and diagnosis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38968?source=see_link\">",
"     \"Viral encephalitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/16/21769?source=see_link\">",
"     \"Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/62/1001?source=see_link\">",
"     \"Herpes simplex virus type 1 encephalitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/62/34789?source=see_link\">",
"     \"PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/5/5208?source=see_link\">",
"     \"Japanese encephalitis: Epidemiology, diagnosis, treatment and prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=see_link\">",
"     \"Arthropod-borne encephalitides\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL CHARACTERISTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular methods are particularly well suited for the diagnosis of CNS infections because CSF and spinal and brain tissue are normally sterile body sites, where any evidence of a microorganism is likely to represent infection, and infections, when present, are typically monomicrobial. Furthermore, CSF typically lacks common inhibitors of polymerase chain reaction (PCR) assays such as heme, endonucleases, and exonucleases that can lead to false negative PCR results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36006/abstract/2\">",
"     2",
"    </a>",
"    ]. As a result, CNS samples may be less prone to common causes of false positive (eg, contamination or presence of nonpathogenic colonization) or false negative (eg, inhibition) results compared with other body sites.",
"   </p>",
"   <p>",
"    Nucleic acid amplification methods are often more sensitive than conventional culture-based or antigen detection methods, and may detect organisms that are nonviable or uncultivable. However, except for herpes simplex virus (HSV) and JC virus, the true clinical sensitivity of most molecular tests for CNS infections is not known because there are few studies utilizing a reference standard (eg, brain biopsy) for comparison.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Commercial versus noncommercial assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Currently, the only commercially available molecular tests with United States Food and Drug Administration (FDA) approval for CSF or CNS specimens target enterovirus from CSF. Most assays in common clinical use are unlicensed laboratory developed tests that have been validated for CNS specimens in laboratories certified to perform high complexity testing. As a result, the majority of assays are not standardized between laboratories and interlaboratory variability is common. Analytical sensitivity may vary significantly and quantitative values (eg, viral load, copy number) are not comparable between laboratories. For both commercial and noncommercial assays, testing specificity for a given organism depends on the uniqueness of the target being amplified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     False positive and negative results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite advances in test design and understanding, false negative and false positive results may still occur and do",
"    <strong>",
"     not",
"    </strong>",
"    always indicate laboratory error or test failure. Potential causes for false negative test results (ie, failure to detect nucleic acid despite active infection due to the targeted pathogen) include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Insufficient analytical sensitivity of a laboratory's assay for the specific microorganism (eg, concentration of the organism [nucleic acid] is below the functional limit of detection)",
"     </li>",
"     <li>",
"      \"Inhibition\" of amplification (most commonly due to a \"bloody tap\", CSF fluid with high number of erythrocytes)",
"     </li>",
"     <li>",
"      Failure of the assay to amplify or detect the intended microorganism in the absence of inhibition (rare, usually due to unrecognized species genetic variation or high rate of mutation, as with RNA viruses)",
"     </li>",
"     <li>",
"      Insufficient clinical sensitivity (eg, concentration of the microorganism is low in the submitted sample due to pathophysiology of the disease [eg, West Nile Virus], prolonged treatment,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      immune clearance)",
"     </li>",
"     <li>",
"      Sampling error (occurs at low nucleic acid concentration and is related to the inherently small test volumes used in molecular testing)",
"     </li>",
"     <li>",
"      Failure to test for the causative organism (eg, appropriate pathogen-specific test not performed, as most molecular tests detect only a single targeted pathogen)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Likewise, a positive nucleic acid amplification (NAA) test result for a specific pathogen may not always indicate CNS disease due to that pathogen and should be interpreted with caution. Due to the extreme sensitivity of these assays, there is an inherent risk of false positive results due to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Amplification of a contaminating organism introduced at the time of specimen collection (eg, nonsterile technique, blood contamination of CSF) or post-collection (eg, in the laboratory)",
"     </li>",
"     <li>",
"      Amplification of a noncausative \"bystander\" (eg, microorganism present in circulating leukocytes that cross the blood-brain barrier during acute inflammation)",
"     </li>",
"     <li>",
"      Amplification of nucleic acid from a latent (not active) infection",
"     </li>",
"     <li>",
"      Lack of specificity of assay primer or probe sequences",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Importance of clinical correlation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Test results should be analyzed in the context of the probability of infection. In the absence of an elevated leukocyte count or elevated protein level in the CSF, the likelihood of a true positive PCR result for an infectious pathogen is significantly reduced, while the number of false positive and uninterpretable results increase. Limiting utilization of CSF PCR tests to those patients with a moderate to high pretest probability of having CNS disease based on clinical presentation, disease prevalence, and CSF parameters increases the predictive value of test results and reduces cost.",
"   </p>",
"   <p>",
"    The efficacy of using screening criteria before molecular diagnostic testing was illustrated by a retrospective review of protein and leukocyte counts for 974 CSF specimens submitted for PCR analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36006/abstract/3\">",
"     3",
"    </a>",
"    ]. Amongst the samples tested for HSV, all 13 of the patients with a positive HSV PCR result had either an elevated CSF white blood cell count or protein level, while none of the 202 samples with normal CSF parameters were positive.",
"   </p>",
"   <p>",
"    However, screening based on the presence or absence of abnormal CSF parameters may not be appropriate for patients who are immunocompromised or for those with intraparenchymal (but not meningeal) inflammation (ie, encephalitis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36006/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ROLE OF MOLECULAR TESTING BY CNS SYNDROME",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Meningitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a patient with suspected meningitis may now routinely include molecular testing, particularly when viral etiologies are considered. Traditional nonmolecular testing remains clinically useful however, and in many cases should be used in conjunction with molecular testing (eg, culture or serologic evaluations). Similarly, CSF cell count, glucose, and protein analyses maintain traditional predictive value and have been examined for their potential in screening CSF samples prior to the performance of molecular testing (eg, enteroviruses, HSV). (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Importance of clinical correlation'",
"    </a>",
"    above)",
"   </p>",
"   <p>",
"    A summary of molecular tests available for specific pathogens and the recommended test method(s) for diagnosis in patients with suspected meningitis is presented in the following table (",
"    <a class=\"graphic graphic_table graphicRef58078 \" href=\"mobipreview.htm?0/39/638\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Bacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gram stain and culture remain the methods of choice for diagnosis of bacterial meningitis and molecular tests are not routinely available. NAA testing may be useful in select cases when uncultivable or fastidious organisms are suspected (eg, Mycoplasma spp, Brucella spp, or Tropheryma whipplei) or when prior antibiotic therapy compromises culture sensitivity, although these assays are not widely available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Mycobacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct detection of M. tuberculosis from CSF (eg, tuberculous meningitis) is routinely available from reference laboratories and recommended as an adjunct to traditional mycobacterial culture when clinical suspicion for tuberculosis meningitis remains high. Mycobacterial culture should also always be ordered when a diagnosis of tuberculous meningitis is suspected given the poor sensitivity of molecular testing from CSF. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/2/28713?source=see_link\">",
"     \"Central nervous system tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Rickettsia and spirochetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular testing for rickettsia and spirochetes is investigational and not routinely available. Serum",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CSF evaluations for serologic response and titers remain the primary methods of diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/48/28425?source=see_link\">",
"     \"Diagnosis of Lyme disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/44/39624?source=see_link\">",
"     \"Diagnostic testing for syphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of molecular methods for the detection of enteroviruses and Herpesviridae (eg, HSV, varicella zoster virus [VZV], cytomegalovirus [CMV], and Epstein Barr virus [EBV]) is standard of care when CNS infection due to these viruses is suspected. However, it should be noted that the majority of enteroviral PCR assays do not detect Parechoviruses, although specific NAA tests for these are available from referral laboratories.",
"   </p>",
"   <p>",
"    Molecular testing for the arthropod transmitted viruses is less well characterized, with the possible exception of West Nile virus (WNV), the only agent for which NAA testing is routinely available. However, evaluation of serum",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CSF for the presence of an antibody response to WNV is preferred to molecular tests for this virus unless patients are immunocompromised. In cases when CNS disease due to respiratory virus is suspected, testing of alternative non-CNS sources (eg, respiratory specimens) alone or in conjunction with CSF optimizes diagnostic yield.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Fungi and parasites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular assays for these agents are rarely available and insufficiently characterized for recommendation. Fungal and parasite stains, culture, histology, and serology are preferred.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Encephalitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of encephalitis is extensive and includes both infectious and non-infectious causes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36006/abstract/6\">",
"     6",
"    </a>",
"    ]. Testing, in particular molecular testing, for specific infectious agents should be guided by epidemiology, risk factors, test availability, and clinical presentation. A combination of traditional diagnostic studies (eg, CSF analysis, imaging) potentially including microbiologic cultures of non-CNS sites should be employed prior to or concurrent with molecular testing. Molecular diagnostic methods should be included in the evaluation of suspected viral encephalitis whenever possible. However, with the exception of HSV encephalitis, the clinical sensitivity and predictive value of molecular testing from CSF for intraparenchymal disease remains largely undefined. Thus, while molecular testing of CSF is considered a primary method of diagnosis for many viral causes of encephalitis (eg, HSV), negative results may not exclude infection and a combined diagnostic approach including serology, imaging, repeat testing, and occasionally biopsy may be necessary to confirm the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/62/34789?source=see_link\">",
"     \"PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Importantly, molecular testing should be negative in postinfectious encephalitis (ie, an immune-mediated disease). The clinical history, serology, and potentially other studies may be necessary to document recent primary infection outside the CNS (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38968?source=see_link\">",
"     \"Viral encephalitis in adults\"",
"    </a>",
"    ). A summary of molecular testing methods that may be useful in the evaluation of patients with encephalitis is provided in the table (",
"    <a class=\"graphic graphic_table graphicRef80353 \" href=\"mobipreview.htm?1/27/1470\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Bacteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meningoencephalitis from bacteria is uncommon, but NAA tests may be useful in selected cases, such as when the exposure or patient history suggest a fastidious, slow-growing or uncultivable bacteria such as Coxiella burnetii [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36006/abstract/7\">",
"     7",
"    </a>",
"    ]. Mycoplasma pneumoniae may be a more common cause of non-viral encephalitis than was previously recognized but NAA testing of CSF has a low diagnostic yield relative to serology. NAA testing of respiratory secretions may support the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36006/abstract/6,8,9\">",
"     6,8,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/5/3162?source=see_link&amp;anchor=H16#H16\">",
"     \"Mycoplasma pneumoniae infection in adults\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Spirochetes, Rickettsia, and Ehrlichiae",
"    </span>",
"    &nbsp;&mdash;&nbsp;NAA testing for spirochetes, Rickettsia, and Ehrlichiae spp are not widely available with the exception of few state public health laboratories. Serum and CSF testing for antibodies remain the primary means of diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular testing (from CSF) is recommended for diagnosing encephalitis due to Herpesviridae, especially HSV (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/62/34789?source=see_link\">",
"     \"PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis\"",
"    </a>",
"    ). For several herpesviruses, quantitative assays are increasingly used to aid in the distinction of latent infection of host leukocytes or chromosomal integration into host cells (eg, HHV-6) from active infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36006/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/1/10265?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of human herpesvirus-6 infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    PCR testing of CSF for rabies virus is one of several tests to confirm a suspected case and is available from the United States Centers for Disease Control and Prevention (CDC) and some state public health laboratories. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although PCR tests are generally available for WNV, testing of serum",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CSF for antibodies is preferred for the diagnosis of WNV encephalitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22264?source=see_link\">",
"     \"Clinical manifestations and diagnosis of West Nile virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    PCR tests for other arthropod borne viral causes of encephalitis (eg, Colorado tick fever, California encephalitis virus, Western equine encephalitis virus) are not routinely available. Mumps and measles remain infrequent but potential causes of encephalitis for which NAA testing is generally not available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Fungi and parasites",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted in the section on meningitis, NAA testing for these organisms remains investigational and not clinically available. If infection due to these organisms is a consideration, traditional methods of diagnosis should be used. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40919?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19494?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cryptococcal meningoencephalitis in HIV seronegative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/41/4762?source=see_link\">",
"     \"Free-living amebas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Transverse myelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although anecdotal reports of success exist, there is relatively little published data from which to judge the sensitivity of molecular testing for the various infectious etiologies of transverse myelitis. Molecular tests should be negative when disease is postinfectious or due to noninfectious inflammatory causes. A table summarizing the potentially useful molecular tests for the evaluation of transverse myelitis is provided (",
"    <a class=\"graphic graphic_table graphicRef59579 \" href=\"mobipreview.htm?2/7/2173\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Brain abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonmolecular methods (eg, stains, culture, histologic examination,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serology or antigen detection) remain the methods of choice to detect bacteria, mycobacteria, fungi (eg, Cryptococcus), and parasites (eg, amebic, Toxoplasma) from intraparenchymal lesions (",
"    <a class=\"graphic graphic_table graphicRef68813 \" href=\"mobipreview.htm?34/26/35244\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38104?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of brain abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Molecular diagnostic tests have dramatically impacted both the diagnosis and management of central nervous system (CNS) infections where rapid, accurate identification of a pathogen and prompt initiation of antimicrobial therapy is potentially lifesaving. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Molecular methods are particularly well suited for the diagnosis of CNS infections because CNS samples are less prone to common causes of false positive (eg, contamination or presence of nonpathogenic colonization) or false negative (eg, inhibition) results compared to other body sites. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General characteristics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nucleic acid amplification methods are often more sensitive than conventional culture-based or antigen detection methods, and may detect organisms that are nonviable or uncultivable. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General characteristics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Except for herpes simplex virus and JC virus, the true clinical sensitivity of most molecular tests for CNS infections is not known because there are few studies utilizing a reference standard (eg, brain biopsy) for comparison. In addition, there remain few FDA-approved assays for CNS samples and the majority of assays in common use are not standardized between laboratories and interlaboratory variability makes quantitative values (eg, viral load, copy number) not comparable between laboratories. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Commercial versus noncommercial assays'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Despite advances in test design and understanding, false negative and false positive results may still occur. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'False positive and negative results'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Test results should always be analyzed in the context of the pretest probability of infection. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Importance of clinical correlation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A summary of molecular test availability for specific pathogens and the recommended test method(s) for diagnosis in patients with suspected meningitis, encephalitis, transverse myelitis, and brain abscess is presented in the tables (",
"      <a class=\"graphic graphic_table graphicRef58078 \" href=\"mobipreview.htm?0/39/638\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef80353 \" href=\"mobipreview.htm?1/27/1470\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef59579 \" href=\"mobipreview.htm?2/7/2173\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef68813 \" href=\"mobipreview.htm?34/26/35244\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Role of molecular testing by CNS syndrome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/1\">",
"      Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis 2004; 4:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/2\">",
"      Debiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 2004; 17:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/3\">",
"      Tang YW, Hibbs JR, Tau KR, et al. Effective use of polymerase chain reaction for diagnosis of central nervous system infections. Clin Infect Dis 1999; 29:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/4\">",
"      Simko JP, Caliendo AM, Hogle K, Versalovic J. Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA. Clin Infect Dis 2002; 35:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/5\">",
"      Davies NW, Brown LJ, Gonde J, et al. Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. J Neurol Neurosurg Psychiatry 2005; 76:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/6\">",
"      Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/7\">",
"      Chesky M, Scalco R, Failace L, et al. Polymerase chain reaction for the laboratory diagnosis of aseptic meningitis and encephalitis. Arq Neuropsiquiatr 2000; 58:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/8\">",
"      Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/9\">",
"      Christie LJ, Honarmand S, Talkington DF, et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 2007; 120:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/10\">",
"      Ward KN, Leong HN, Thiruchelvam AD, et al. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 2007; 45:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36006/abstract/11\">",
"      Granerod J, Cunningham R, Zuckerman M, et al. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 2010; 138:783.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1278 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-221.179.173.170-9A4DD99832-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36006=[""].join("\n");
var outline_f35_10_36006=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL CHARACTERISTICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Commercial versus noncommercial assays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      False positive and negative results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Importance of clinical correlation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ROLE OF MOLECULAR TESTING BY CNS SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Meningitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Bacteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Mycobacteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Rickettsia and spirochetes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Viruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Fungi and parasites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Encephalitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Bacteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Spirochetes, Rickettsia, and Ehrlichiae",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Viruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Fungi and parasites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Transverse myelitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/1278\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1278|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/39/638\" title=\"table 1\">",
"      Molecular tests for meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/27/1470\" title=\"table 2\">",
"      Molecular test encephalitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/7/2173\" title=\"table 3\">",
"      Molecular test transverse myelitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/26/35244\" title=\"table 4\">",
"      Molecular test brain lesion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/16/21769?source=related_link\">",
"      Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/54/38760?source=related_link\">",
"      Arthropod-borne encephalitides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/3/15417?source=related_link\">",
"      Aseptic meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/2/28713?source=related_link\">",
"      Central nervous system tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22264?source=related_link\">",
"      Clinical manifestations and diagnosis of West Nile virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19494?source=related_link\">",
"      Clinical manifestations and diagnosis of cryptococcal meningoencephalitis in HIV seronegative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29624?source=related_link\">",
"      Clinical manifestations and diagnosis of rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/1/10265?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of human herpesvirus-6 infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/48/28425?source=related_link\">",
"      Diagnosis of Lyme disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/44/39624?source=related_link\">",
"      Diagnostic testing for syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/61/40919?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of cryptococcal meningoencephalitis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/41/4762?source=related_link\">",
"      Free-living amebas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/62/1001?source=related_link\">",
"      Herpes simplex virus type 1 encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/5/5208?source=related_link\">",
"      Japanese encephalitis: Epidemiology, diagnosis, treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/5/3162?source=related_link\">",
"      Mycoplasma pneumoniae infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/62/34789?source=related_link\">",
"      PCR testing for the diagnosis of herpes simplex virus in patients with encephalitis or meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38104?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38968?source=related_link\">",
"      Viral encephalitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/21/10586?source=related_link\">",
"      Viral meningitis: Clinical features and diagnosis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_10_36007="Causes of syncope in children and adolescents";
var content_f35_10_36007=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of syncope in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36007/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36007/contributors\">",
"     Brian Coleman, MD, MSE",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36007/contributors\">",
"     Jack C Salerno, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36007/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36007/contributors\">",
"     George A Woodward, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36007/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36007/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36007/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/10/36007/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syncope is a sudden, brief loss of consciousness associated with loss of postural tone from which recovery is spontaneous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/1\">",
"     1",
"    </a>",
"    ]. Up to 15 percent of children experience a syncopal episode prior to the end of adolescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the etiology of syncopal events in children is most often benign, syncope can also occur as the result of more serious (usually cardiac) disease with the potential for sudden death. The vast majority of cases of syncope in the pediatric age group represent benign alterations in vasomotor tone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Life-threatening causes of syncope generally have a cardiac etiology (",
"    <a class=\"graphic graphic_table graphicRef60014 \" href=\"mobipreview.htm?36/49/37660\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This topic will review the serious and benign causes of syncope. A discussion of the emergent evaluation and algorithmic approach to children and adolescents with syncope is presented separately (",
"    <a class=\"graphic graphic_algorithm graphicRef53383 \" href=\"mobipreview.htm?0/49/784\">",
"     algorithm 1",
"    </a>",
"    ). The evaluation of adults with syncope is also discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11432?source=see_link\">",
"     \"Emergent evaluation of syncope in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/15/18682?source=see_link\">",
"     \"Evaluation of syncope in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LIFE-THREATENING CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Life-threatening cardiac conditions cause syncope as the result of an abrupt decrease in cardiac output, either from an arrhythmia or related to structural heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/5\">",
"     5",
"    </a>",
"    ]. Arrhythmias are typically tachyarrhythmias. In children, syncope caused by isolated bradycardia (ie, complete AV block) is uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/24/33161?source=see_link&amp;anchor=H6#H6\">",
"     \"Bradycardia in children\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Primary electrical disturbances can occur in patients with structurally normal hearts. These arrhythmias may be related to exogenous factors (ie, a metabolic disturbance or drug ingestion) or an inherited electrophysiologic abnormality (ie, congenital long QT syndrome). Arrhythmias may also develop as the result of structural heart disease, such as myocarditis or repaired congenital heart disease. Finally, syncope can occur in conditions such as aortic stenosis and hypertrophic cardiomyopathy (HCM) as the result of left ventricular outflow tract obstruction and compromised systemic blood flow, particularly during exercise.",
"   </p>",
"   <p>",
"    Although rare, cardiac causes of syncope can be life-threatening. A review of the literature describing ventricular arrhythmias in children noted the following mortality risks for comparison [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unselected population 1 to 18 years of age: 0.00001 cases per patient year",
"     </li>",
"     <li>",
"      Long QT syndrome: 0.001 cases per patient year",
"     </li>",
"     <li>",
"      High-risk tetralogy of Fallot and congenital heart disease patients: 0.03 cases per patient year",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Infant/pediatric",
"      </span>",
"      dilated cardiomyopathy: 0.14 to 0.3 cases per patient year",
"     </li>",
"     <li>",
"      Myocardial infarction survivors, depressed ventricular function: 0.2 cases per patient year",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Primary electrical disturbances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients without structural heart disease who develop syncope as the result of ventricular arrhythmias may have inherited primary electrical disturbances. These conditions are much less common causes of syncope than structural lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/12/15559?source=see_link\">",
"     \"Sudden cardiac arrest in the absence of apparent structural heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Long QT syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long QT syndrome (LQTS) is a disorder of myocardial repolarization characterized by prolongation of QT interval on the electrocardiogram and an increased risk of sudden death due to the potential to degenerate into polymorphic ventricular tachycardia (",
"    <a class=\"graphic graphic_waveform graphicRef77018 \" href=\"mobipreview.htm?26/24/27008\">",
"     waveform 1",
"    </a>",
"    ). Long QT syndrome may be acquired or congenital.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acquired LQTS usually results from drug therapy or electrolyte disturbances (",
"      <a class=\"graphic graphic_table graphicRef57431 \" href=\"mobipreview.htm?2/48/2830\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=see_link&amp;anchor=H4#H4\">",
"       \"Acquired long QT syndrome\", section on 'Drug-induced TdP'",
"      </a>",
"      .) Patients with eating disorders may have prolongation of the QT interval, as well as other ECG abnormalities. These changes typically normalize during nutritional rehabilitation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=see_link&amp;anchor=H22#H22\">",
"       \"Acquired long QT syndrome\", section on 'Additional therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Two clinical phenotypes of congenital LQTS have been described. The more common autosomal dominant form, the Romano-Ward syndrome, has a purely cardiac phenotype. The autosomal recessive form, the Jervell and Lange-Nielsen syndrome, is associated with LQTS and sensorineural deafness and a more malignant clinical course. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link\">",
"       \"Clinical features of congenital long QT syndrome\"",
"      </a>",
"      .) Causes of acquired LQTS (ie, drugs, hypokalemia, and hypomagnesemia) can also precipitate ventricular arrhythmia in patients with congenital LQTS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prolongation of the QT interval is an essential component of the diagnosis of LQTS. However, the QTc varies in response to a number of factors, such as autonomic state, electrolyte imbalance, drugs, and diurnal changes. Thus, a normal QTc measurement on a single ECG does not exclude the possibility of long QT syndrome. The hand calculated QTc interval, in combination with clinical and historical features, can be used to establish the diagnosis of congenital LQTS in some cases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/6/33897?source=see_link&amp;anchor=H16#H16\">",
"     \"Diagnosis of congenital long QT syndrome\", section on 'LQTS score'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/6/33897?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnosis of congenital long QT syndrome\", section on 'QT interval'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Brugada syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Brugada syndrome (BS) have a characteristic pattern on electrocardiogram (ECG) and an increased risk of sudden death. Sudden cardiac death may be the first and only clinical event in BS, occurring in as many as one-third of patients. Arrhythmic events generally occur between ages 22 and 65, although cases in children as young as three years of age have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. Arrhythmic events in children with BS are uncommon, but may be more likely during febrile episodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/37/28250?source=see_link&amp;anchor=H9#H9\">",
"     \"Brugada syndrome\", section on 'Age at diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Typical ECG findings include pseudo-right bundle branch block and persistent ST segment elevation in leads V1 to V3 (",
"    <a class=\"graphic graphic_waveform graphicRef64510 \" href=\"mobipreview.htm?8/35/8762\">",
"     waveform 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/37/28250?source=see_link&amp;anchor=H2#H2\">",
"     \"Brugada syndrome\", section on 'ECG patterns'",
"    </a>",
"    .) ECG changes may be transient in some patients.",
"   </p>",
"   <p>",
"    A number of antiarrhythmic, antianginal, and psychotropic drugs can induce a Brugada-like ECG pattern (",
"    <a class=\"graphic graphic_table graphicRef73611 \" href=\"mobipreview.htm?20/53/21340\">",
"     table 3",
"    </a>",
"    ). The Brugada syndrome is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/37/28250?source=see_link\">",
"     \"Brugada syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Catecholaminergic polymorphic ventricular tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with catecholaminergic polymorphic ventricular tachycardia (VT) may present during childhood or adolescence with syncope as the result of VT or ventricular fibrillation (VF) induced by emotional or physical stress. Familial and sporadic cases occur and several genetic patterns have been described. Arrhythmias typically cannot be induced at electrophysiologic study, but can be provoked by exercise testing or IV catecholamine infusion. A detailed discussion of catecholaminergic polymorphic ventricular tachycardia can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37641?source=see_link&amp;anchor=H3#H3\">",
"     \"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval\", section on 'Catecholaminergic polymorphic VT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Preexcitation syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among children and young adults who suffer sudden death, a preexcitation syndrome (such as Wolff-Parkinson-White) may be the underlying cause (",
"    <a class=\"graphic graphic_waveform graphicRef76226 \" href=\"mobipreview.htm?35/41/36506\">",
"     waveform 3",
"    </a>",
"    ). This association was described in a prospective series of 273 children or young adults who died suddenly and had a prior ECG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/12\">",
"     12",
"    </a>",
"    ]. A preexcitation syndrome was noted in 10 subjects (3.6 percent). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/54/31593?source=see_link&amp;anchor=H15#H15\">",
"     \"Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia\", section on 'Ventricular fibrillation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Congenital short QT syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association of sudden cardiac death, syncope, or atrial fibrillation and short QT interval has been noted in multiple case reports, including several children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/13\">",
"     13",
"    </a>",
"    ]. Three genetic mutations have been described. The corrected QT interval (QTc) in this syndrome is &le;0.30 sec. Congenital short QT syndrome is considerably less common than long QT syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/12/15559?source=see_link&amp;anchor=H9#H9\">",
"     \"Sudden cardiac arrest in the absence of apparent structural heart disease\", section on 'Short QT syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Structural heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syncope may be life-threatening for children with structural heart disease. Among young athletes with sudden death, the majority have unrecognized structural heart lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/36/13898?source=see_link&amp;anchor=H12#H12\">",
"     \"Risk of sudden cardiac death in athletes\", section on 'Structural abnormalities associated with SCD'",
"    </a>",
"    .) Children with congenital heart disease, including those who have undergone surgical palliation or correction, are also at risk for malignant arrhythmias. In particular, repaired defects such as tetralogy of Fallot, aortic stenosis, and transposition of great arteries have been associated with sudden cardiac death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/7,15-18\">",
"     7,15-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Hypertrophic cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertrophic cardiomyopathy (HCM) is a relatively common autosomal dominant disorder (incidence of 1 in 500 in the general population) that is characterized by asymmetric hypertrophy of the left ventricle. Patients may experience exertional syncope. HCM is the most common cause of sudden death during exercise. Mechanisms that lead to inadequate cardiac output include left ventricular outflow obstruction, ischemia during exertion, and arrhythmia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Coronary artery anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital abnormalities in the origin of the coronary arteries may present as syncope or sudden death in teenagers and young adults. An abnormally located coronary artery (as an example, between the aorta and pulmonary artery) may become compressed during exercise, resulting in myocardial ischemia and syncope or sudden death. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/56/14218?source=see_link&amp;anchor=H2#H2\">",
"     \"Congenital and pediatric coronary artery abnormalities\", section on 'Variations of coronary artery origin from the aorta'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Arrhythmogenic right ventricular cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) may present with an arrhythmia of right ventricular (RV) origin",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sudden death. Presentation is most common between the ages of 10 and 50, with a mean age at diagnosis of approximately 30 years. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Valvar aortic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the majority of children with aortic stenosis are asymptomatic, sudden death can occur. In one series, sudden death was reported in 5 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/19\">",
"     19",
"    </a>",
"    ]. These patients were almost all older than 10 years and had significant obstruction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    aortic regurgitation (AR); 19 had prior surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/28/38345?source=see_link&amp;anchor=H9#H9\">",
"     \"Valvar aortic stenosis in children\", section on 'Clinical course'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Dilated cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dilated cardiomyopathy may develop in association with a variety of conditions, the majority of which are idiopathic. Other causes include viral myocarditis, severe anemia, and in patients with muscular dystrophy. Patients with cardiomyopathy who develop syncope as the result of ventricular arrhythmias also typically have severe heart failure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/0/19465?source=see_link\">",
"     \"Causes of dilated cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Pulmonary hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with pulmonary hypertension, either idiopathic or related to a congenital heart defect with a systemic to pulmonary shunt (Eisenmenger syndrome), may experience syncope. However, most patients initially develop exertional dyspnea. Syncope is an indication of more severe pulmonary hypertension and impaired right heart function. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/47/19193?source=see_link\">",
"     \"Overview of pulmonary hypertension in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/55/6007?source=see_link\">",
"     \"Evaluation and prognosis of Eisenmenger syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Acute myocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syncope may occur in patients with acute myocarditis as the result of ventricular dysfunction or arrhythmia. Common viruses include Coxsackie A and B and adenovirus. However, these conditions rarely present as an isolated syncopal event. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/53/34647?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations and diagnosis of myocarditis in children\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     COMMON CONDITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Vasovagal syncope",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasovagal syncope (also known as neurocardiogenic, reflex, or situational syncope, and common fainting) is the most common cause of syncope among children, accounting for 50 percent or more of cases presenting to the emergency department [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Typical clinical features are a precipitating event and a prodrome.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Precipitating events include standing or stress (physical or emotional), although reflex precipitants (such as swallowing, hair grooming, and micturition) have been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/20,21\">",
"       20,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients typically describe a prodrome, which may include lightheadedness, dizziness, visual changes (decrease acuity, tunnel vision, or double vision), nausea, pallor, and diaphoresis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The underlying mechanism for the syncopal episode is an exaggeration of reflex-mediated alterations in vasomotor tone and heart rate normally responsible for maintaining blood pressure (",
"    <a class=\"graphic graphic_figure graphicRef80233 \" href=\"mobipreview.htm?37/2/37926\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/0/18442?source=see_link\">",
"     \"Reflex syncope\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Breath holding spells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breath holding spells typically occur in children 6 months to 24 months of age and are triggered by an emotional insult, such as pain, anger, or fear. The spells may be cyanotic or pallid. The cyanotic variety begins with breath holding, followed by cyanosis and loss of consciousness. In a pallid spell, loss of consciousness occurs before breath holding. Brief posturing or tonic-clonic motor activity may occur with either cyanotic or pallid spells. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/51/24376?source=see_link&amp;anchor=H8#H8\">",
"     \"Nonepileptic paroxysmal disorders in infancy\", section on 'Breath-holding spells'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical course for children with breath holding spells is generally benign. Spells typically stop by five years of age. Some children go on to develop vasovagal syncope [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/22\">",
"     22",
"    </a>",
"    ]. Breath holding spells may represent a variation of vasovagal (neurocardiogenic) syncope. Autonomic dysfunction appears to play a role in both cyanotic and pallid breath holding spells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Orthostatic hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syncope that occurs with postural change may be related to an abrupt drop in blood pressure. Orthostatic hypotension can result from volume depletion (hemorrhage or dehydration), pregnancy (venous pooling), anemia, and medications that alter vasomotor tone and heart rate such as calcium channel blockers, vasodilators, phenothiazines, and diuretics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Toxic exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intoxication may present as syncope, either from decreased cardiac output (barbiturates, tricyclic antidepressants, and phenothiazines) or sudden loss of consciousness (cocaine, alcohol, marijuana, inhalants, and opiates). Some of these agents (such as tricyclic antidepressants and cocaine) may also cause life-threatening syncope. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Life-threatening conditions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Severe carbon monoxide poisoning can cause syncope as the result of QT prolongation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/25\">",
"     25",
"    </a>",
"    ]. Other clinical features (such as history of exposure, headache, and nausea) may suggest carbon monoxide poisoning. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/6/10345?source=see_link&amp;anchor=H5#H5\">",
"     \"Carbon monoxide poisoning\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     OTHER CONDITIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypoglycemia &ndash; Hypoglycemia is frequently cited as a cause of syncope; however, outside of the insulin-dependent diabetic it is an uncommon cause of syncope [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/18,26\">",
"       18,26",
"      </a>",
"      ]. Before the onset of syncope, patients with hypoglycemia frequently report feeling weak, hungry, and sweaty. As blood glucose continues to fall they may exhibit agitation, confusion, and finally altered mental status. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8201?source=see_link&amp;anchor=H5#H5\">",
"       \"Approach to hypoglycemia in infants and children\", section on 'Clinical features'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16010?source=see_link\">",
"       \"Etiology of hypoglycemia in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arrhythmias (not life-threatening) &ndash; Rhythm disturbances (other than vagally mediated syncope) that are not ventricular in origin may cause syncope that is not life-threatening.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Supraventricular tachycardia",
"      </strong>",
"      &ndash; Syncope is an unusual presentation of supraventricular tachycardia. Accessory pathway mediated tachycardia and atrioventricular nodal reentry tachycardia are relatively common arrhythmias, but rarely present with syncope. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/54/31593?source=see_link&amp;anchor=H14#H14\">",
"       \"Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia\", section on 'Syncope and atrial fibrillation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Bradycardia",
"      </strong>",
"      &ndash; In children, syncope caused by isolated bradycardia is unusual [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/6\">",
"       6",
"      </a>",
"      ]. Causes of symptomatic bradycardia in children are corrective surgery for congenital heart disease, hypervagotonia, hypothyroidism, and medications (such as beta adrenergic blockers). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/24/33161?source=see_link\">",
"       \"Bradycardia in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anaphylaxis can involve syncope and loss of consciousness, and patients or caregivers sometime overlook or forget the more subtle, earlier symptoms, such as flushing, itching, hives, cough and bronchospasm, or abdominal cramping. In addition, these less dramatic symptoms may have resolved by the time the patient is evaluated. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=see_link&amp;anchor=H2#H2\">",
"       \"Anaphylaxis: Rapid recognition and treatment\", section on 'Definition and diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CONDITIONS THAT MIMIC SYNCOPE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conditions that may mimic syncope include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seizures &ndash; A seizure typically includes loss of consciousness and postural tone. However, seizures usually last longer than syncopal episodes and include features such as an aura, prolonged tonic clonic activity,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the presence of a postictal phase.",
"     </li>",
"     <li>",
"      Migraine syndromes &ndash; Migraine syndromes, particularly basilar migraines, may present with symptoms that are similar to syncope such as loss of conscious, ataxia, or vertigo. Loss of consciousness is usually longer than several seconds. In addition, patients generally have other neurologic symptoms, as well as headache and nausea. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44743?source=see_link&amp;anchor=H3#H3\">",
"       \"Basilar-type migraine\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Hysteria/conversion",
"      </span>",
"      disorder &ndash;",
"      <span class=\"nowrap\">",
"       Hysteria/conversion",
"      </span>",
"      disorder is most common in adolescent patients. These events typically occur in the presence of an audience, lack hemodynamic (heart rate, blood pressure) or autonomic (sweating, pallor) changes, may be prolonged, and rarely result in injury. Patients typically describe the event in a calm indifferent manner. They may disclose details of the event that indicate no loss of consciousness.",
"     </li>",
"     <li>",
"      Hyperventilation &ndash; Hyperventilation is usually associated with emotional stress. It occurs more commonly in adolescent patients. The patient may complain of chest pain, chest tightness, and shortness of breath. In addition, symptoms may include lightheadedness, paresthesias, and visual disturbances.",
"     </li>",
"     <li>",
"      Choking game &ndash; The choking game is defined as self-strangulation or strangulation by another person with the hands or a ligature to produce a euphoric state caused by cerebral hypoxia. The plan is to release the pressure just before loss of consciousness, but failure to do so can result in death, particularly when the game is played alone using ligatures. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/49/3864?source=see_link\">",
"       \"The &ldquo;choking game&rdquo; and other strangulation activities in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syncope is a sudden, brief loss of consciousness associated with loss of postural tone from which recovery is spontaneous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36007/abstract/1\">",
"     1",
"    </a>",
"    ]. Although the etiology of syncopal events in children is most often benign, syncope can also occur as the result of more serious (usually cardiac) disease with the potential for sudden death (",
"    <a class=\"graphic graphic_table graphicRef60014 \" href=\"mobipreview.htm?36/49/37660\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef53383 \" href=\"mobipreview.htm?0/49/784\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Life-threatening conditions that cause syncope generally have a cardiac etiology. They include primary electrical disturbances (either congenital or acquired, such as from a drug effect or an electrolyte disturbance) and structural heart disease. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Life-threatening conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common conditions that cause syncope include vasovagal syncope, breath holding spells, and orthostatic hypotension. Toxic exposures, hypoglycemia, and arrhythmias can also cause syncope. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Common conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conditions that mimic syncope include seizures, migraine syndromes, hysteria, and hyperventilation. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Conditions that mimic syncope'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/1\">",
"      Kapoor WN. Syncope. N Engl J Med 2000; 343:1856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/2\">",
"      Lewis DA, Dhala A. Syncope in the pediatric patient. The cardiologist's perspective. Pediatr Clin North Am 1999; 46:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/3\">",
"      Pratt JL, Fleisher GR. Syncope in children and adolescents. Pediatr Emerg Care 1989; 5:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/4\">",
"      Massin MM, Bourguignont A, Coremans C, et al. Syncope in pediatric patients presenting to an emergency department. J Pediatr 2004; 145:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/5\">",
"      Gillette PC, Garson A Jr. Sudden cardiac death in the pediatric population. Circulation 1992; 85:I64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/6\">",
"      Strickberger SA, Benson DW, Biaggioni I, et al. AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Circulation 2006; 113:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/7\">",
"      Alexander ME, Berul CI. Ventricular arrhythmias: when to worry. Pediatr Cardiol 2000; 21:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/8\">",
"      Mivelaz Y, Di Bernardo S, Pruvot E, et al. Brugada syndrome in childhood: a potential fatal arrhythmia not always recognised by paediatricians. A case report and review of the literature. Eur J Pediatr 2006; 165:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/9\">",
"      Probst V, Evain S, Gournay V, et al. Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child. J Cardiovasc Electrophysiol 2006; 17:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/10\">",
"      Probst V, Denjoy I, Meregalli PG, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007; 115:2042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/11\">",
"      Skinner JR, Chung SK, Nel CA, et al. Brugada syndrome masquerading as febrile seizures. Pediatrics 2007; 119:e1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/12\">",
"      Basso C, Corrado D, Rossi L, Thiene G. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death. Circulation 2001; 103:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/13\">",
"      Schimpf R, Wolpert C, Gaita F, et al. Short QT syndrome. Cardiovasc Res 2005; 67:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/14\">",
"      Maron BJ. Sudden death in young athletes. N Engl J Med 2003; 349:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/15\">",
"      Garson A Jr, Smith RT, Moak JP, et al. Ventricular arrhythmias and sudden death in children. J Am Coll Cardiol 1985; 5:130B.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/16\">",
"      Rocchini AP, Chun PO, Dick M. Ventricular tachycardia in children. Am J Cardiol 1981; 47:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/17\">",
"      Garson A Jr. Arrhythmias in pediatric patients. Med Clin North Am 1984; 68:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/18\">",
"      Driscoll DJ, Jacobsen SJ, Porter CJ, Wollan PC. Syncope in children and adolescents. J Am Coll Cardiol 1997; 29:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/19\">",
"      Keane JF, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis. Circulation 1993; 87:I16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/20\">",
"      Strieper MJ. Distinguishing benign syncope from life-threatening cardiac causes of syncope. Semin Pediatr Neurol 2005; 12:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/21\">",
"      Igarashi M, Boehm RM Jr, May WN, Bornhofen JH. Syncope associated with hair-grooming. Brain Dev 1988; 10:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/22\">",
"      DiMario FJ Jr. Prospective study of children with cyanotic and pallid breath-holding spells. Pediatrics 2001; 107:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/23\">",
"      DiMario FJ Jr, Burleson JA. Autonomic nervous system function in severe breath-holding spells. Pediatr Neurol 1993; 9:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/24\">",
"      DiMario FJ Jr, Bauer L, Baxter D. Respiratory sinus arrhythmia in children with severe cyanotic and pallid breath-holding spells. J Child Neurol 1998; 13:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/25\">",
"      Onvlee-Dekker IM, De Vries AC, Ten Harkel AD. Carbon monoxide poisoning mimicking long-QT induced syncope. Arch Dis Child 2007; 92:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36007/abstract/26\">",
"      Scott WA. Evaluating the child with syncope. Pediatr Ann 1991; 20:350.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6466 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-115.124.72.62-8E1C3CC7B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36007=[""].join("\n");
var outline_f35_10_36007=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LIFE-THREATENING CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Primary electrical disturbances",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Brugada syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Catecholaminergic polymorphic ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Preexcitation syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Congenital short QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Coronary artery anomalies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Valvar aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Acute myocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      COMMON CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Vasovagal syncope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Breath holding spells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Orthostatic hypotension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      OTHER CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CONDITIONS THAT MIMIC SYNCOPE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6466\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6466|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?0/49/784\" title=\"algorithm 1\">",
"      Emergent evaluation of pediatric syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6466|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/2/37926\" title=\"figure 1\">",
"      Neural pathways in syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6466|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/49/37660\" title=\"table 1\">",
"      Causes of syncope children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/48/2830\" title=\"table 2\">",
"      Causes of long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/53/21340\" title=\"table 3\">",
"      Drugs that can induce Brugada-like ECG patterns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6466|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?26/24/27008\" title=\"waveform 1\">",
"      Prolonged QT interval tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?8/35/8762\" title=\"waveform 2\">",
"      ECG Brugada syndrome type I pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?35/41/36506\" title=\"waveform 3\">",
"      ECG sinus rhythm WPW",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8201?source=related_link\">",
"      Approach to hypoglycemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44743?source=related_link\">",
"      Basilar-type migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/24/33161?source=related_link\">",
"      Bradycardia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/37/28250?source=related_link\">",
"      Brugada syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/6/10345?source=related_link\">",
"      Carbon monoxide poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37641?source=related_link\">",
"      Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/0/19465?source=related_link\">",
"      Causes of dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32106?source=related_link\">",
"      Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/53/34647?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/56/14218?source=related_link\">",
"      Congenital and pediatric coronary artery abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/6/33897?source=related_link\">",
"      Diagnosis of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11432?source=related_link\">",
"      Emergent evaluation of syncope in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16010?source=related_link\">",
"      Etiology of hypoglycemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/55/6007?source=related_link\">",
"      Evaluation and prognosis of Eisenmenger syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/15/18682?source=related_link\">",
"      Evaluation of syncope in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/51/24376?source=related_link\">",
"      Nonepileptic paroxysmal disorders in infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/47/19193?source=related_link\">",
"      Overview of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/0/18442?source=related_link\">",
"      Reflex syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/36/13898?source=related_link\">",
"      Risk of sudden cardiac death in athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/12/15559?source=related_link\">",
"      Sudden cardiac arrest in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/54/31593?source=related_link\">",
"      Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/49/3864?source=related_link\">",
"      The &ldquo;choking game&rdquo; and other strangulation activities in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/28/38345?source=related_link\">",
"      Valvar aortic stenosis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_10_36008="Pathophysiology and treatment of edema in patients with the nephrotic syndrome";
var content_f35_10_36008=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathophysiology and treatment of edema in patients with the nephrotic syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36008/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36008/contributors\">",
"     Jai Radhakrishnan, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36008/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36008/contributors\">",
"     Richard J Glassock, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36008/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36008/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/10/36008/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H613074949\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Edema is one of the major clinical manifestations of the nephrotic syndrome. The pathophysiology and treatment of edema in patients with the nephrotic syndrome will be reviewed here. More general issues such as the clinical manifestations, diagnosis, and general principles of the treatment of edema are discussed elsewhere as is the mechanism of hypoalbuminemia in the nephrotic syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/36/34375?source=see_link\">",
"     \"Clinical manifestations and diagnosis of edema in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/50/30503?source=see_link\">",
"     \"General principles of the treatment of edema in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/18/32041?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of heavy proteinuria and the nephrotic syndrome\", section on 'Hypoalbuminemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     UNDERFILLING VERSUS RENAL SODIUM RETENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two major factors, both of which lead to retention, have been thought to be responsible the development of edema in patients with the nephrotic syndrome; it is likely that both contribute to a variable degree in individual patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary sodium retention that is directly induced by the renal disease (",
"      <strong>",
"       overfill",
"      </strong>",
"      hypothesis).",
"     </li>",
"     <li>",
"      Secondary sodium retention in which the low plasma oncotic pressure due to hypoalbuminemia promotes the movement of fluid from the vascular space into the interstitium, leading to underfilling of the vasculature and activation of the renin-angiotensin-aldosterone system (",
"      <strong>",
"       underfill",
"      </strong>",
"      hypothesis).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical importance of distinguishing between these mechanisms is the ability to tolerate diuretic therapy. Diuretics are well tolerated in patients with renal sodium retention but, if underfilling is the primary mechanism, can lead to worsening hypovolemia as evidenced clinically by an elevation in serum creatinine. As will be described below, most patients tolerate diuretic therapy at least initially.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Starling's law",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possible importance of arterial underfilling seems to be predicted from Starling's law, which states that the exchange of fluid between the plasma and the interstitium is determined by the hydraulic and oncotic pressures in each compartment:",
"   </p>",
"   <p>",
"    Net filtration across the capillary wall",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp;= &nbsp; LpS &nbsp; x &nbsp;",
"    <span class=\"nowrap\">",
"     (&Delta;",
"    </span>",
"    hydraulic pressure &nbsp; - &nbsp;",
"    <span class=\"nowrap\">",
"     &Delta;",
"    </span>",
"    oncotic pressure)",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp;= &nbsp; LpS &nbsp; x &nbsp; [(Pcap &nbsp;- &nbsp; Pif) &nbsp; - &nbsp; s(&pi;cap &nbsp; - &nbsp; &pi;if)]",
"   </p>",
"   <p>",
"    where Lp is the unit permeability (or porosity) of the capillary wall, S is the surface area available for fluid movement, Pcap and Pif are the capillary and interstitial fluid hydraulic pressures, &pi;cap and &pi;if are the capillary and interstitial fluid oncotic pressures, and s represents the reflection coefficient of proteins across the capillary wall (with values ranging from 0 if completely permeable to 1 if completely impermeable). The interstitial oncotic pressure is derived primarily from filtered plasma proteins and to a lesser degree proteoglycans in the interstitium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h3\">",
"     Application to nephrotic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;At first glance, a reduction in plasma oncotic pressure induced by hypoalbuminemia would seem to favor the movement of fluid out of the vascular space into the interstitium and produce arterial underfilling. However, it is the",
"    <strong>",
"     transcapillary oncotic pressure gradient",
"    </strong>",
"    (plasma minus interstitium), not the plasma oncotic pressure alone, that acts to hold fluid within the vascular space. The normal interstitial oncotic pressure in humans is 10 to 15 mmHg (compared with about 26 mmHg in the plasma) due in part to accumulation of some of the small amount of albumin that is filtered across the capillary wall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/1,3\">",
"     1,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This distinction is important since the gradual fall in plasma oncotic pressure in the nephrotic syndrome is associated with a",
"    <strong>",
"     parallel decline",
"    </strong>",
"    in interstitial oncotic pressure (",
"    <a class=\"graphic graphic_figure graphicRef74352 \" href=\"mobipreview.htm?26/17/26908\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/3,4\">",
"     3,4",
"    </a>",
"    ], which minimizes the change in the transcapillary oncotic pressure gradient and therefore minimizes fluid movement out of the vascular space and results in relative maintenance of the plasma volume. The following factors contribute to this protective response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypoalbuminemia is associated with less albumin entry into the interstitium",
"     </li>",
"     <li>",
"      The fluid that moves from the vascular space into the interstitium will lower the interstitial albumin concentration by dilution",
"     </li>",
"     <li>",
"      There is increased lymphatic flow which, by bulk flow, will remove albumin as well",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As a result, there is usually little change in the transcapillary oncotic pressure gradient in patients with nephrotic syndrome and therefore little tendency to plasma volume depletion, unless the hypoalbuminemia is severe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/6\">",
"     6",
"    </a>",
"    ]. Similarly, the plasma volume is typically preserved after diuretic therapy for edema removal in patients with nephrotic syndrome as long as the patient is not overdiuresed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The response is appreciably different after the rapid administration of large volumes of saline to patients with marked hypovolemia due to bleeding (eg, ruptured aortic aneurysm). In this setting, there is an",
"    <strong>",
"     acute",
"    </strong>",
"    dilutional reduction in the plasma albumin concentration without time for the interstitial albumin concentration to fall. As a result, the transcapillary oncotic pressure gradient is reduced and peripheral edema due to fluid movement out of the vascular space can occur before the restoration of normal intracardiac filling pressures.",
"   </p>",
"   <p>",
"    It is important to appreciate that the absence of demonstrable plasma volume depletion when a nephrotic patient is edematous does not preclude an important role for underfilling. Initial underfilling can activate compensatory mechanisms (such as enhanced renin release) that then return the plasma volume toward normal at the price of extracellular volume expansion and edema. Such a sequence clearly occurs in heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Furthermore, patients with the nephrotic syndrome do not have the clear signs of volume expansion (and occasionally pulmonary edema) as can be seen with renal sodium retention due to acute glomerulonephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Evidence supporting underfilling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following findings support an important role for hypoalbuminemia and underfilling in the pathogenesis of edema in some patients with the nephrotic syndrome:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some patients, primarily those with minimal change disease (MCD), have low rates of sodium excretion and elevated plasma renin activity, findings suggestive of volume depletion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/6,11,12\">",
"       6,11,12",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H613074727\">",
"       'Volume regulatory hormones'",
"      </a>",
"      below.) One study, for example, evaluated 30 children with early relapse of MCD who were studied within a",
"      <strong>",
"       few days",
"      </strong>",
"      of the onset of relapse as indicated by persistent 3+ findings on the urine dipstick for protein; 21 had edema at the time of evaluation and were evaluated for symptoms or signs of hypovolemia which included tachycardia, peripheral vasoconstriction (eg, cold hands and feet), and oliguria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/12\">",
"       12",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Compared with the eight asymptomatic patients, the 13 patients with hypovolemic signs or symptoms had a higher plasma renin activity, higher plasma aldosterone and norepinephrine concentrations, and more sodium avidity as evidenced by a lower fractional excretion of sodium. The differences between the two groups could not be explained by differences in proteinuria or the degree of hypoproteinemia.",
"     </li>",
"     <li>",
"      The normal serum total protein concentration is 6 to 8",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (60 to 80",
"      <span class=\"nowrap\">",
"       g/L),",
"      </span>",
"      a little more than one-half of which (3.5 to 5.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [35 to 50",
"      <span class=\"nowrap\">",
"       g/L])",
"      </span>",
"      is normally comprised of albumin. The findings in the preceding study of children with early relapse of MCD are consistent with dog studies in which severe reductions in the total protein concentration (mean 2.4",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [24",
"      <span class=\"nowrap\">",
"       g/L],",
"      </span>",
"      normal 7.2",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [72",
"      <span class=\"nowrap\">",
"       g/L])",
"      </span>",
"      produced by plasmapheresis plus isotonic fluid replacement led to significant reductions in plasma volume and blood pressure and increases in plasma renin activity and plasma aldosterone concentration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/13,14\">",
"       13,14",
"      </a>",
"      ]. These hemodynamic changes were not seen with moderate reductions in total protein concentration to approximately 4.8",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (48",
"      <span class=\"nowrap\">",
"       g/L)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Starling&rsquo;s law predicts that, with increasingly",
"      <strong>",
"       severe",
"      </strong>",
"      hypoalbuminemia, washout of the interstitial oncotic pressure would eventually be complete and that further reductions in the plasma oncotic pressure would lower the transcapillary oncotic pressure gradient and tend to produce underfilling. Support for this hypothesis comes from a study of 22 children with nephrotic syndrome not due to minimal change disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/15\">",
"       15",
"      </a>",
"      ]. Sixteen children had stable edema",
"      <strong>",
"       without",
"      </strong>",
"      marked sodium retention or changes in volume regulatory hormones; these patients had a mean plasma albumin concentration of 2.1",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (21",
"      <span class=\"nowrap\">",
"       g/L).",
"      </span>",
"      In contrast, six had clinical (tachycardia, vasoconstriction, pallor, oliguria) and hormonal evidence of hypovolemia; these patients, four of whom had congenital nephrotic syndrome of the Finnish type, had a mean plasma albumin concentration of 0.8",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (8",
"      <span class=\"nowrap\">",
"       g/L).",
"      </span>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/36/7753?source=see_link\">",
"       \"Congenital and infantile nephrotic syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The administration of albumin to raise the plasma oncotic pressure can increase sodium excretion and lead to resolution of edema [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]. However, this response is not seen in all patients and is not predictably seen in the same patient studied on several occasions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Evidence supporting primary renal sodium retention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in experimental animals with unilateral nephrotic syndrome or glomerulonephritis suggest that primary sodium retention in these disorders is due to increased sodium reabsorption in the collecting tubules (",
"    <a class=\"graphic graphic_figure graphicRef82649 \" href=\"mobipreview.htm?27/23/28029\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], which is also the site of action of atrial natriuretic peptide (ANP) and the related renal hormone urodilatin. This has been called the overfill hypothesis, since primary renal sodium retention leads to volume expansion, as opposed to underfilling as discussed in the preceding section,",
"   </p>",
"   <p>",
"    Several different abnormalities in tubular function have been identified in the nephrotic syndrome, which could increase sodium reabsorption:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is increased activity of the Na-K-ATPase pump in the cortical collecting tubule but not other nephron segments [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/20\">",
"       20",
"      </a>",
"      ]. This pump provides the energy for active sodium transport by pumping reabsorbed sodium out of the cell into the peritubular capillary. However, it is not clear if this represents a primary effect or is simply a secondary marker for increased sodium transport at this site.",
"     </li>",
"     <li>",
"      Both experimental and human studies have documented relative resistance to atrial natriuretic peptide and urodilatin in the nephrotic syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/1,21-23\">",
"       1,21-23",
"      </a>",
"      ]. This defect is due at least in part to increased phosphodiesterase activity in the collecting tubules, leading to more rapid degradation of the second messenger of ANP, cyclic GMP (guanosine monophosphate). Infusion of a phosphodiesterase inhibitor largely reverses this defect and restores the normal natriuretic response to volume expansion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. The mechanism by which phosphodiesterase activity is increased in the nephrotic syndrome is not known but phosphodiesterase-mediated resistance to ANP has also been described in heart failure and cirrhosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased activity of the epithelial sodium channel (ENaC) may contribute to sodium retention [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/24,25\">",
"       24,25",
"      </a>",
"      ]. Serine proteases (plasmin in particular) in nephrotic urine may activate ENaC via proteolytic cleavage of the gamma chain, providing a potential mechanism by which filtered proteins cause sodium retention. It also explains the observation that remission from the nephrotic syndrome is generally preceded by a decrease in urinary protein excretion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another possible contributor to renal sodium retention is enhanced proximal tubular reabsorption via increased activity of the sodium-hydrogen exchanger (NHE3) that mediates a large part of proximal sodium reabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. However, even if proximal sodium reabsorption were increased, it might not contribute to sodium retention since, as mentioned above in the unilateral nephrotic syndrome model, delivery to the end-distal tubule appears to be the same in nephrotic and non-nephrotic kidneys (",
"    <a class=\"graphic graphic_figure graphicRef82649 \" href=\"mobipreview.htm?27/23/28029\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H613074727\">",
"    <span class=\"h3\">",
"     Volume regulatory hormones",
"    </span>",
"    &nbsp;&mdash;&nbsp;The plasma levels of volume regulatory hormones have been measured in nephrotic patients in an attempt to more clearly define the volume status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/28\">",
"     28",
"    </a>",
"    ]. Normal subjects ingesting and excreting 20 meq of sodium per day have a high plasma renin activity (PRA) and low atrial natriuretic peptide (ANP) levels. In comparison, most nephrotic patients (at the same low level of sodium excretion) have renin and ANP levels that are equivalent to those in normal subjects ingesting 120 to 150",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef50596 \" href=\"mobipreview.htm?24/39/25213\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    These findings suggest at least a component of primary renal sodium retention, since sodium excretion is much lower than expected from the plasma hormone levels. However, nephrotic patients with edema do not have the hormonal profile (very low PRA, very high ANP) seen in acute glomerulonephritis, which is thought to represent an example of pure volume expansion due to renal sodium retention (",
"    <a class=\"graphic graphic_figure graphicRef50596 \" href=\"mobipreview.htm?24/39/25213\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another finding that might favor of a component of underfilling in the nephrotic syndrome is the frequent presence of nonosmotic release of antidiuretic hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. However, this change is not of major physiologic importance since, in the absence of renal failure, nephrotic patients do not usually develop the water retention and hyponatremia seen in patients with heart failure and cirrhosis, conditions in which decreased effective circulating volume provides the stimulus for hormonal activation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38742?source=see_link\">",
"     \"Hyponatremia in patients with heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/12/17608?source=see_link\">",
"     \"Hyponatremia in patients with cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Response to glucocorticoids in MCD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observations in patients with minimal change disease (MCD) have suggested a relatively minor role for hypoalbuminemia (unless severe) in the development of nephrotic edema in many patients. When remission is induced by glucocorticoids, the peak diuresis typically occurs",
"    <strong>",
"     before",
"    </strong>",
"    there is a substantial rise in the plasma oncotic pressure (",
"    <a class=\"graphic graphic_figure graphicRef55827 \" href=\"mobipreview.htm?14/42/15021\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/31\">",
"     31",
"    </a>",
"    ]. It is possible, however, that even a small elevation in the plasma albumin concentration is sufficient to reverse underfilling and permit a diuresis. Thus, these observations do not necessarily exclude a pathogenetic role for underfilling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Varying mechanisms in childhood minimal change disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study in children with minimal change disease (MCD) sheds some light on the often conflicting findings noted above, since it suggests that patients with the same disease may have different mechanisms of edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/12\">",
"     12",
"    </a>",
"    ]. Thirty children with MCD in remission were monitored carefully and studied within a",
"    <strong>",
"     few days",
"    </strong>",
"    of the onset of relapse as indicated by persistent 3+ findings on the urine dipstick for protein. When first evaluated, three different groups were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nine appeared to have",
"      <strong>",
"       primary renal sodium retention",
"      </strong>",
"      . They were relatively normoalbuminemic (mean plasma albumin concentration 3.7",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [37",
"      <span class=\"nowrap\">",
"       g/L]),",
"      </span>",
"      had a reduced fractional excretion of sodium (0.5 versus 1.1 percent in remission), and signs of modest volume expansion (weight gain, increased blood volume) but no overt edema since the degree of volume expansion was not yet great enough.",
"     </li>",
"     <li>",
"      Thirteen appeared to have",
"      <strong>",
"       underfilling",
"      </strong>",
"      . In addition to edema, overt nephrotic syndrome, and a mean plasma albumin concentration of 1.6",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (16",
"      <span class=\"nowrap\">",
"       g/L),",
"      </span>",
"      they also had one or more symptoms suggestive of volume depletion (tachycardia, peripheral vasoconstriction, oliguria), marked elevations in the plasma renin activity and plasma concentrations of aldosterone and norepinephrine, low plasma concentration of atrial natriuretic peptide, and a low glomerular filtration rate. In one child, the symptoms and neurohumoral activation were transiently improved by albumin infusion.",
"     </li>",
"     <li>",
"      Eight had edema, overt nephrotic syndrome, and a mean plasma albumin concentration of 1.8",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (18",
"      <span class=\"nowrap\">",
"       g/L),",
"      </span>",
"      but no signs of hypovolemia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The factors responsible for the differences between the last two groups with the same degree of hypoalbuminemia are not well understood. One possibility is that patients with rapid protein loss may have a reduction in the transcapillary oncotic pressure gradient because there has not been sufficient time for the interstitial oncotic pressure to fall. If this were the case, then underfilling should be transient, disappearing as the interstitial oncotic pressure fell in parallel to the change in the plasma oncotic pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hypoalbuminemia in other edematous disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observations in conditions other than the nephrotic syndrome have been used to evaluate the role of hypoalbuminemia and presumed underfilling in the pathogenesis of edema. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with cirrhosis are frequently hypoalbuminemic but typically present with ascites (due to postsinusoidal obstruction), not prominent peripheral edema.",
"     </li>",
"     <li>",
"      Edema is common in the malnutrition syndrome kwashiorkor. Although this complication has been ascribed to hypoalbuminemia, it has been suggested that increased generation of cysteinyl leukotrienes may be of major importance by increasing capillary permeability [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Conclusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;It seems likely that the relative importance of underfilling due to hypoalbuminemia and overfilling due to primary renal sodium retention varies among patients and, perhaps at different times, in the same patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/12\">",
"     12",
"    </a>",
"    ]. Some have suggested that the renal findings at presentation may be helpful but the predictive value is uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/11,33\">",
"     11,33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with elevated intravascular volume due to primary renal sodium retention are more likely have a glomerular filtration rate less than 50 percent of normal, a plasma albumin concentration greater than 2",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (20",
"      <span class=\"nowrap\">",
"       g/L),",
"      </span>",
"      and hypertension.",
"     </li>",
"     <li>",
"      Patients with underfilling are more likely to have a glomerular filtration rate greater than 75 percent of normal and either minimal change disease of acute onset or severe hypoalbuminemia (often below 1",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [10",
"      <span class=\"nowrap\">",
"       g/L])",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/12,15\">",
"       12,15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Independent of the mechanism of nephrotic edema, underfilling can occur after the initiation of diuretic therapy as discussed below. (See",
"    <a class=\"local\" href=\"#H23421802\">",
"     'Diuretics and sodium restriction'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The above discussion on the roles of underfilling and primary renal sodium retention was provided to describe the mechanisms of edema formation in the nephrotic syndrome. However, distinction between these mechanisms prior to the initiation of diuretic therapy (eg, measurement of plasma renin activity, plasma aldosterone, and plasma natriuretic peptides) is",
"    <strong>",
"     not",
"    </strong>",
"    made in routine clinical practice. Clinically, children may present with underfilling or primary sodium retention, whereas primary sodium retention predominates in adults. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/33/6679?source=see_link&amp;anchor=H4#H4\">",
"     \"Symptomatic management of nephrotic syndrome in children\", section on 'Diuretics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23421802\">",
"    <span class=\"h2\">",
"     Diuretics and sodium restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with nephrotic edema are initially treated with diuretic therapy and dietary sodium restriction (approximately 2",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    and monitored for clinical signs of hypovolemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/34\">",
"     34",
"    </a>",
"    ]. The excess fluid can usually be removed, at least initially, without inducing clinically significant plasma volume depletion as defined by an otherwise unexplained elevation in serum creatinine or clinical manifestations of hypovolemia (eg, weakness, orthostatic hypotension,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cool extremities) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/7\">",
"     7",
"    </a>",
"    ]. Careful monitoring is required and diuretic therapy should be at least temporarily discontinued if these manifestations occur. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/56/24457?source=see_link&amp;anchor=H9#H9\">",
"     \"Etiology, clinical manifestations, and diagnosis of volume depletion in adults\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40710?source=see_link&amp;anchor=H4#H4\">",
"     \"Loop diuretics: Maximum effective dose and major side effects\", section on 'Major side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients respond well to loop diuretics, although there is generally a lesser natriuresis than seen in normal subjects even when the glomerular filtration rate is normal or near normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. Several factors are thought to play an important role in this relative diuretic resistance:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All the commonly used diuretics are highly protein-bound. This limits the diuretic to the vascular space, thereby maximizing its rate of delivery to the kidney. The degree of protein-binding is reduced with hypoalbuminemia, resulting in a larger extravascular space of distribution and a slower rate of delivery to the kidney [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/35,36\">",
"       35,36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Some of the diuretic that enters the tubular lumen is bound to filtered albumin and rendered inactive [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/38,39\">",
"       38,39",
"      </a>",
"      ]. In experimental in vivo microperfusion of the loop of Henle, the addition of albumin to the perfusate in a concentration similar to that seen in the tubular lumen in the nephrotic syndrome diminishes the response to intraluminal",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      by about 50 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/38\">",
"       38",
"      </a>",
"      ]. However, it is uncertain if this mechanism is important in humans. In one study of seven patients with nephrotic syndrome, blocking of albumin binding to furosemide by the administration of sulfisoxazole had no effect on the diuretic response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Studies in rats with drug-induced nephrotic syndrome suggest that the loop of Henle may be relatively resistant to loop diuretics [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The net effect is that the effective diuretic dose is usually higher in patients with nephrotic syndrome compared with other edematous disorders. As an example, the maximum dose of intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    is 40 to 80 mg in edematous patients with heart failure or cirrhosis who have a relatively normal glomerular filtration rate, but may be as high as 80 to 120 mg in patients with the nephrotic syndrome and a relatively normal glomerular filtration rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/12\">",
"     12",
"    </a>",
"    ]. Patients who do not respond adequately may require the addition of a thiazide diuretic to block sodium reabsorption at several sites in the nephron. These issues are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40710?source=see_link\">",
"     \"Loop diuretics: Maximum effective dose and major side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/40/650?source=see_link&amp;anchor=H18#H18\">",
"     \"Treatment of refractory edema in adults\", section on 'Thiazide plus loop diuretics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has been suggested that the diuresis can be enhanced in patients with marked hypoalbuminemia by infusing a solution in which a loop diuretic has been added to salt-poor albumin, creating loop diuretic-albumin complexes that keep the diuretic within the vascular space, thereby increasing the rate of loop diuretic secretion into the tubular lumen. However, the efficacy of such an approach has not been proven. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/40/650?source=see_link&amp;anchor=H16#H16\">",
"     \"Treatment of refractory edema in adults\", section on 'Infusion with albumin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704527486\">",
"    <span class=\"h2\">",
"     Angiotensin inhibition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all patients with proteinuric chronic kidney disease are given, in addition to appropriate therapy for the underlying disease, an ACE inhibitor or an angiotensin II receptor blocker in an attempt to slow the progressive loss of kidney function. A possible additional benefit of such therapy among diuretic-resistant patients is a lesser degree of albuminuria, which might increase the plasma albumin concentration and enhance the response to diuretics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36008/abstract/37\">",
"     37",
"    </a>",
"    ]. Minimal change disease is a major exception to this approach since remission can usually be induced with glucocorticoid therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41130?source=see_link&amp;anchor=H79962422#H79962422\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\", section on 'Renin-angiotensin system inhibitors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/9/31898?source=see_link&amp;anchor=H445388995#H445388995\">",
"     \"Treatment of minimal change disease in adults\", section on 'Glucocorticoid therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/53/32594?source=see_link\">",
"       \"Patient information: Edema (swelling) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/2/35875?source=see_link\">",
"       \"Patient information: The nephrotic syndrome (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1038562\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Edema (swelling) is the major clinical manifestation of the nephrotic syndrome. There are two mechanisms responsible for the development of edema in patients with the nephrotic syndrome: low plasma levels of albumin which promotes the movement of fluid out of the vascular, leading to underfilling of the vasculature and secondary sodium retention; and primary sodium retention induced by the renal disease. It is likely that both can contribute to a variable degree in individual patients. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Underfilling versus renal sodium retention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although an important role of arterial underfilling appears to be predicted from Starling's law, the gradual fall in plasma oncotic pressure in the nephrotic syndrome is associated with a parallel decline in interstitial oncotic pressure, which minimizes the change in the transcapillary oncotic pressure gradient. This minimizes fluid movement out of the vascular space, resulting in many patients in relative maintenance of the plasma volume. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Starling's law'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      However, underfilling does occur, particularly in children with minimal change disease of acute onset or severe hypoalbuminemia (often below 1",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [10",
"      <span class=\"nowrap\">",
"       g/L]).",
"      </span>",
"      Such patients may have symptoms or signs of hypovolemia, including tachycardia, peripheral vasoconstriction (eg, cold hands and feet), and oliguria. In addition, patients with symptomatic hypovolemia, compared with asymptomatic patients, have a higher plasma renin activity, higher plasma aldosterone and norepinephrine concentrations, and more sodium avidity as evidenced by a lower fractional excretion of sodium. In the absence of symptoms or signs, the major manifestation of underfilling is an otherwise unexplained elevation in serum creatinine with diuretic therapy in patients who still have edema. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Evidence supporting underfilling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of primary renal sodium retention as a cause for nephrotic edema is supported by both experimental models and observations in nephrotic patients. Experimental models suggest that the sodium retention is due to increased sodium reabsorption in the collecting tubules. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Evidence supporting primary renal sodium retention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Studies in children with minimal change disease have shown that either underfilling or primary renal sodium retention can be the mechanism for edema. In adults, the majority of patients present with primary sodium retention. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Varying mechanisms in childhood minimal change disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following clinical characteristics have been suggested to help determine whether underfilling or sodium retention is the predominant mechanism in nephrotic edema (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Conclusion'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients with elevated intravascular volume due to primary renal sodium retention are more likely have a glomerular filtration rate less than 50 percent of normal, a plasma albumin concentration greater than 2",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (20",
"      <span class=\"nowrap\">",
"       g/L),",
"      </span>",
"      and hypertension.",
"     </li>",
"     <li>",
"      Patients with underfilling are more likely to have a glomerular filtration rate greater than 75 percent of normal and either minimal change disease of acute onset or severe hypoalbuminemia (often below 1",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      [10",
"      <span class=\"nowrap\">",
"       g/L]).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend that patients with nephrotic edema who do not have otherwise unexplained signs of symptoms of hypovolemia (eg, tachycardia, peripheral vasoconstriction, cold hands and feet) be treated with diuretic therapy and dietary sodium restriction (approximately 2 g of sodium per day) (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Excess fluid can usually be removed without inducing clinically significant plasma volume depletion. The effective diuretic dose is usually higher in patients with nephrotic syndrome compared with other edematous disorders and the addition of a thiazide diuretic may be required. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Treatment'",
"      </a>",
"      above.)",
"      <br/>",
"     </li>",
"     <li>",
"      Almost all patients with proteinuric chronic kidney disease are given, in addition to therapy specific for the underlying cause of the nephrotic syndrome, an ACE inhibitor or an angiotensin II receptor blocker in an attempt to slow the progressive loss of kidney function. Minimal change disease is a major exception to this approach since remission can usually be induced with glucocorticoid therapy. A possible additional benefit of angiotensin inhibition in diuretic-resistant patients is a decrease in the severity of albuminuria, which might increase the plasma albumin concentration and enhance the response to diuretics. (See",
"      <a class=\"local\" href=\"#H704527486\">",
"       'Angiotensin inhibition'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/1\">",
"      Perico N, Remuzzi G. Edema of the nephrotic syndrome: the role of the atrial peptide system. Am J Kidney Dis 1993; 22:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/2\">",
"      Humphreys MH. Mechanisms and management of nephrotic edema. Kidney Int 1994; 45:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/3\">",
"      Noddeland H, Riisnes SM, Fadnes HO. Interstitial fluid colloid osmotic and hydrostatic pressures in subcutaneous tissue of patients with nephrotic syndrome. Scand J Clin Lab Invest 1982; 42:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/4\">",
"      Koomans HA, Kortlandt W, Geers AB, Dorhout Mees EJ. Lowered protein content of tissue fluid in patients with the nephrotic syndrome: observations during disease and recovery. Nephron 1985; 40:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/5\">",
"      Aukland K, Nicolaysen G. Interstitial fluid volume: local regulatory mechanisms. Physiol Rev 1981; 61:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/6\">",
"      Geers AB, Koomans HA, Roos JC, et al. Functional relationships in the nephrotic syndrome. Kidney Int 1984; 26:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/7\">",
"      Geers AB, Koomans HA, Roos JC, Dorhout Mees EJ. Preservation of blood volume during edema removal in nephrotic subjects. Kidney Int 1985; 28:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/8\">",
"      Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981; 63:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/9\">",
"      Watkins L Jr, Burton JA, Haber E, et al. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 1976; 57:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/10\">",
"      EISENBERG S. Blood volume in patients with acute glomerulonephritis as determined by radioactive chromium tagged red cells. Am J Med 1959; 27:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/11\">",
"      Meltzer JI, Keim HJ, Laragh JH, et al. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med 1979; 91:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/12\">",
"      Vande Walle JG, Donckerwolcke RA, van Isselt JW, et al. Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 1995; 346:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/13\">",
"      Manning RD Jr, Guyton AC. Effects of hypoproteinemia on fluid volumes and arterial pressure. Am J Physiol 1983; 245:H284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/14\">",
"      Manning RD Jr. Effects of hypoproteinemia on renal hemodynamics, arterial pressure, and fluid volume. Am J Physiol 1987; 252:F91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/15\">",
"      Vande Walle JG, Donckerwolcke RA, Koomans HA. Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol 1999; 10:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/16\">",
"      EDER HA, LAUSON HD, CHINARD FP, et al. A study of the mechanisms of edema formation in patients with the nephrotic syndrome. J Clin Invest 1954; 33:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/17\">",
"      LUETSCHER JA Jr, HALL AD, KREMER VL. Treatment of nephrosis with concentrated human serum albumin. II. Effects on renal function and on excretion of water and some electrolytes. J Clin Invest 1950; 29:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/18\">",
"      Ichikawa I, Rennke HG, Hoyer JR, et al. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 1983; 71:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/19\">",
"      Buerkert J, Martin DR, Trigg D, Simon EE. Sodium handling by deep nephrons and the terminal collecting duct in glomerulonephritis. Kidney Int 1991; 39:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/20\">",
"      F&eacute;raille E, Vogt B, Rousselot M, et al. Mechanism of enhanced Na-K-ATPase activity in cortical collecting duct from rats with nephrotic syndrome. J Clin Invest 1993; 91:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/21\">",
"      Valentin JP, Ying WZ, Sechi LA, et al. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis. J Am Soc Nephrol 1996; 7:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/22\">",
"      Valentin JP, Qiu C, Muldowney WP, et al. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome. J Clin Invest 1992; 90:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/23\">",
"      Lee EY, Humphreys MH. Phosphodiesterase activity as a mediator of renal resistance to ANP in pathological salt retention. Am J Physiol 1996; 271:F3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/24\">",
"      Svenningsen P, Bistrup C, Friis UG, et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 2009; 20:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/25\">",
"      Passero CJ, Mueller GM, Rondon-Berrios H, et al. Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. J Biol Chem 2008; 283:36586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/26\">",
"      Besse-Eschmann V, Klisic J, Nief V, et al. Regulation of the proximal tubular sodium/proton exchanger NHE3 in rats with puromycin aminonucleoside (PAN)-induced nephrotic syndrome. J Am Soc Nephrol 2002; 13:2199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/27\">",
"      Klisic J, Zhang J, Nief V, et al. Albumin regulates the Na+/H+ exchanger 3 in OKP cells. J Am Soc Nephrol 2003; 14:3008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/28\">",
"      Rodr&iacute;guez-Iturbe B, Colic D, Parra G, Gutkowska J. Atrial natriuretic factor in the acute nephritic and nephrotic syndromes. Kidney Int 1990; 38:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/29\">",
"      Usberti M, Federico S, Meccariello S, et al. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int 1984; 25:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/30\">",
"      Pyo HJ, Summer SN, Niederberger M, et al. Arginine vasopressin gene expression in rats with puromycin-induced nephrotic syndrome. Am J Kidney Dis 1995; 25:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/31\">",
"      Koomans HA, Boer WH, Dorhout Mees EJ. Renal function during recovery from minimal lesions nephrotic syndrome. Nephron 1987; 47:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/32\">",
"      Mayatepek E, Becker K, Gana L, et al. Leukotrienes in the pathophysiology of kwashiorkor. Lancet 1993; 342:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/33\">",
"      Schrier RW, Fassett RG. A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney Int 1998; 53:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/34\">",
"      Crew RJ, Radhakrishnan J, Appel G. Complications of the nephrotic syndrome and their treatment. Clin Nephrol 2004; 62:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/35\">",
"      Smith DE, Hyneck ML, Berardi RR, Port FK. Urinary protein binding, kinetics, and dynamics of furosemide in nephrotic patients. J Pharm Sci 1985; 74:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/36\">",
"      Keller E, Hoppe-Seyler G, Schollmeyer P. Disposition and diuretic effect of furosemide in the nephrotic syndrome. Clin Pharmacol Ther 1982; 32:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/37\">",
"      Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 2002; 13:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/38\">",
"      Kirchner KA, Voelker JR, Brater DC. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome. J Pharmacol Exp Ther 1990; 252:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/39\">",
"      Kirchner KA, Voelker JR, Brater DC. Binding inhibitors restore furosemide potency in tubule fluid containing albumin. Kidney Int 1991; 40:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/40\">",
"      Agarwal R, Gorski JC, Sundblad K, Brater DC. Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. J Am Soc Nephrol 2000; 11:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36008/abstract/41\">",
"      Kirchner KA, Voelker JR, Brater DC. Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats. J Am Soc Nephrol 1992; 2:1201.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3044 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-197.136.42.3-D0BB386C34-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36008=[""].join("\n");
var outline_f35_10_36008=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1038562\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H613074949\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      UNDERFILLING VERSUS RENAL SODIUM RETENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Starling's law",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      - Application to nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Evidence supporting underfilling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Evidence supporting primary renal sodium retention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H613074727\">",
"      - Volume regulatory hormones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Response to glucocorticoids in MCD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Varying mechanisms in childhood minimal change disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hypoalbuminemia in other edematous disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Conclusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23421802\">",
"      Diuretics and sodium restriction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H704527486\">",
"      Angiotensin inhibition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1038562\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3044\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3044|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/17/26908\" title=\"figure 1\">",
"      Oncotic pressures in nephrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/23/28029\" title=\"figure 2\">",
"      Na handling in nephrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/39/25213\" title=\"figure 3\">",
"      Hormonal changes in nephrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/42/15021\" title=\"figure 4\">",
"      Diuresis in minimal change",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/36/34375?source=related_link\">",
"      Clinical manifestations and diagnosis of edema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/36/7753?source=related_link\">",
"      Congenital and infantile nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/56/24457?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of volume depletion in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/50/30503?source=related_link\">",
"      General principles of the treatment of edema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/12/17608?source=related_link\">",
"      Hyponatremia in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38742?source=related_link\">",
"      Hyponatremia in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/48/40710?source=related_link\">",
"      Loop diuretics: Maximum effective dose and major side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/18/32041?source=related_link\">",
"      Overview of heavy proteinuria and the nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/53/32594?source=related_link\">",
"      Patient information: Edema (swelling) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/2/35875?source=related_link\">",
"      Patient information: The nephrotic syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/33/6679?source=related_link\">",
"      Symptomatic management of nephrotic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/9/31898?source=related_link\">",
"      Treatment of minimal change disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/40/650?source=related_link\">",
"      Treatment of refractory edema in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_10_36009="The endothelium: A primer";
var content_f35_10_36009=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The endothelium: A primer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36009/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36009/contributors\">",
"     Katherine A Hajjar, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36009/contributors\">",
"     William C Aird, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36009/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36009/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/10/36009/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/10/36009/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/10/36009/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1854190\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelial cells (ECs) form the lining of all blood and lymphatic vessels within the vascular tree. The adult human body contains at least one trillion endothelial cells, which weigh more than 100 g and cover a surface area of more than 3000 square meters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. They therefore constitute a distributed organ that forms a dynamic interface with all other organs in the body.",
"   </p>",
"   <p>",
"    The endothelium mediates vasomotor tone, regulates cellular and nutrient trafficking, maintains blood fluidity, contributes to the local balance between pro- and anti-inflammatory mediators as well as procoagulant and anticoagulant activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/3\">",
"     3",
"    </a>",
"    ], participates in generation of new blood vessels, interacts with circulating blood cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/4\">",
"     4",
"    </a>",
"    ], and undergoes programmed cell death. Each of these activities is dynamically regulated in both space and time. Because endothelial cells receive cues from a wide variety of cells and tissues, they possess disparate properties that are specific to their local environment. This &ldquo;heterogeneity&rdquo; is a central feature of the endothelium, and includes variations in morphology, biosynthetic repertoire, and behavior [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Here we review some of the general features of the endothelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Organ-specific considerations, which are presented separately, include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The cardiovascular system &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/39/23162?source=see_link\">",
"       \"Endothelial dysfunction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/40/28297?source=see_link&amp;anchor=H2#H2\">",
"       \"Vascular endothelial function and fundamental mechanisms of fibrinolysis (thrombolysis)\", section on 'Vascular endothelium'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary disorders &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/8/7304?source=see_link\">",
"       \"Pathogenesis of pulmonary hypertension\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/4/38982?source=see_link&amp;anchor=H3#H3\">",
"       \"Inhaled nitric oxide in adults with pulmonary hypertension\", section on 'Physiology'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/15/29945?source=see_link\">",
"       \"Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/39/28282?source=see_link&amp;anchor=H2#H2\">",
"       \"Transfusion-related acute lung injury (TRALI)\", section on 'Pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Malignancy &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/60/1994?source=see_link\">",
"       \"Overview of angiogenesis inhibitors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diabetes &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/45/30422?source=see_link&amp;anchor=H8#H8\">",
"       \"Pathogenesis of diabetic retinopathy\", section on 'Growth factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Obstetrical disorders &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=see_link&amp;anchor=H10#H10\">",
"       \"Pathogenesis of preeclampsia\", section on 'Systemic endothelial dysfunction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infection &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5449?source=see_link&amp;anchor=H15#H15\">",
"       \"Pathophysiology of sepsis\", section on 'Circulation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/51/4920?source=see_link&amp;anchor=H3#H3\">",
"       \"Pathogenesis of hantavirus infections\", section on 'Tissue tropism'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hematology &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14330?source=see_link&amp;anchor=H13#H13\">",
"       \"Vasoocclusion in sickle cell disease\", section on 'Blood vessels'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/32/39434?source=see_link&amp;anchor=H15#H15\">",
"       \"Clinical variability in sickle cell anemia\", section on 'Vascular endothelium'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link&amp;anchor=H12#H12\">",
"       \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\", section on 'Other mechanisms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hepatology &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/4/40009?source=see_link&amp;anchor=H3#H3\">",
"       \"Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation\", section on 'Pathology and pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neurology &mdash; (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/10/17576?source=see_link&amp;anchor=H7#H7\">",
"       \"Cerebrospinal fluid: Physiology and utility of an examination in disease states\", section on 'Microbe entry in meningitis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854489\">",
"    <span class=\"h1\">",
"     THE ENDOTHELIUM FROM BENCH TO BEDSIDE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human endothelial cells were first propagated in culture in the early 1970s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/7\">",
"     7",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    Although there have been major subsequent advances in our understanding of endothelial cell (EC) biology based upon this critically important technology, it is still apparent that ECs tend to dedifferentiate and lose their specialized characteristics in culture. Limitations to studying ECs in vivo include the absence of effective imaging techniques, the dearth of suitable biomarkers reflecting their biologic behavior, and their distinct structural and functional heterogeneity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854496\">",
"    <span class=\"h1\">",
"     ENDOTHELIAL HETEROGENEITY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854504\">",
"    <span class=\"h2\">",
"     Complex signaling patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelial cells receive and respond to signals from both surrounding cells and tissues, and flowing blood. Afferent signals are provided by soluble mediators, cell contacts, changes in oxygenation, hemodynamic forces, temperature, and pH. Efferent responses modulate vasomotor tone, vascular permeability, hemostatic balance, inflammatory signals, as well as cellular proliferation and survival. The response of the EC to a given stimulus may vary dramatically from one vascular bed to another.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854511\">",
"    <span class=\"h2\">",
"     Structural specializations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In different vascular beds, ECs develop discrete ultrastructural specializations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/8\">",
"     8",
"    </a>",
"    ]. In the central nervous system, for example, the endothelium is &ldquo;continuous&rdquo; with complex tight junctions that form the blood-brain barrier. ECs in the endocrine glands and renal glomeruli are &ldquo;discontinuous&rdquo; and &ldquo;fenestrated,&rdquo; with transcellular pores that permit hormone protein secretion and plasma filtration. ECs that allow the exchange of cells or particles are &ldquo;discontinuous&rdquo; and &ldquo;non-fenestrated,&rdquo; displaying gaps between adjacent cells; these cells typify hematopoietic tissues (eg, splenic cords). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/41/17046?source=see_link&amp;anchor=H5#H5\">",
"     \"Red blood cell mechanics\", section on 'Membrane deformability and stability'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854527\">",
"    <span class=\"h2\">",
"     Temporal variations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a given vascular bed, EC properties differ from one moment to the next as they respond to physiologic and pathophysiologic stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. This heterogeneity contributes to the frequently focal nature of vasculopathic disease states.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854534\">",
"    <span class=\"h2\">",
"     Changing synthetic repertoires",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in genomics and proteomics have uncovered an expansive array of site-specific properties of the endothelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. These characteristics reflect differences in programs of protein synthesis, and result from specific signals that originate in the surrounding cells and tissues.",
"   </p>",
"   <p>",
"    The following three examples show how this variability may be clinically relevant:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Anatomic variation",
"      </strong>",
"      &mdash; The",
"      <span class=\"nowrap\">",
"       procoagulant/anticoagulant",
"      </span>",
"      balance appears to differ significantly between the endothelium of the venous valvular sinus and vein lumen, with the valvular sinus endothelium shifted to a more thromboresistant phenotype resulting from increased expression of endothelial protein C receptor and thrombomodulin, and decreased expression of von Willebrand factor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Vascular bed variation",
"      </strong>",
"      &mdash; In patients with thrombotic thrombocytopenia purpura-hemolytic uremic syndrome (TTP-HUS), differences in vascular endothelial damage might reflect the fact that CD36, the thrombospondin receptor, is found on human microvascular ECs (HMVEC), but not ECs of large (umbilical) vessels (HUVEC). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=see_link&amp;anchor=H12#H12\">",
"       \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\", section on 'Other mechanisms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Temporal variation",
"      </strong>",
"      &mdash; In a transgenic mouse model of sickle cell disease (SCD), EC expression of tissue factor was confined almost exclusively to the pulmonary veins [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/17\">",
"       17",
"      </a>",
"      ]. This expression increased significantly following exposure of the mild SCD mouse models to one cycle of",
"      <span class=\"nowrap\">",
"       hypoxia/reoxygenation,",
"      </span>",
"      converting the phenotype to that of the severe SCD mouse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854541\">",
"    <span class=\"h1\">",
"     PATTERNS OF CHANGE IN ENDOTHELIAL FUNCTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854549\">",
"    <span class=\"h2\">",
"     EC activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Originally, the term \"endothelial cell activation\" was based on the observation that cultured ECs demonstrated increased leukocyte adhesion following exposure to inflammatory mediators. The term was expanded later to embrace a wider spectrum of phenotypic changes, including decreased thromboresistance, altered vasomotor tone, and loss of barrier function. According to this paradigm, quiescent ECs display a thromboresistant, anti-adhesive and vasodilatory phenotype, whereas activated ECs have procoagulant, pro-adhesive, and vasoconstricting properties.",
"   </p>",
"   <p>",
"    However, to avoid oversimplification with regard to the state of EC activation, it is important to remember the following points:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The phenotypic spectrum of ECs is a dynamic continuum.",
"     </li>",
"     <li>",
"      Activation for one type of EC may not meet the definition of activation at another site. For example, non-inflamed skin venules express P-selectin constitutively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/18\">",
"       18",
"      </a>",
"      ], whereas venules from other sites (eg, the mesentery) express P-selectin only when activated",
"     </li>",
"     <li>",
"      Inflammatory mediators such as tumor necrosis factor-alpha, thrombin, and lipopolysaccharide may have distinct or only partially overlapping effects on EC phenotypes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      EC activation is not an all-or-nothing response, nor is it necessarily linked to disease. Normal endothelium is highly responsive to alterations in the local extracellular milieu. Such environmental changes might occur in the setting of transient bacteremia, minor trauma, and other common stresses (eg, small temperature changes, proteolytic activity, and shear stress), and can be transient and mild or sustained and severe.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854563\">",
"    <span class=\"h2\">",
"     EC dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initially, EC dysfunction referred to EC structural changes, loss of integrity, or hyperadhesiveness of the vascular lining toward platelets as might be seen in atherosclerosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. More, recently, this term has come to reflect the loss of the endothelium's ability to regulate vascular resistance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854578\">",
"    <span class=\"h2\">",
"     Nitric oxide production",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal physiologic stimulus for endothelial NO synthesis is blood flow-induced shear stress, a process termed \"flow-mediated vasodilatation.\" (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/39/23162?source=see_link&amp;anchor=H2#H2\">",
"     \"Endothelial dysfunction\", section on 'Endothelial physiology'",
"    </a>",
"    .) In addition, a variety of agonists, including acetylcholine, histamine, thrombin, serotonin, adenosine diphosphate, bradykinin, and norepinephrine, can increase the synthesis and release of NO. These agonists result in vasorelaxation when the endothelium is intact, and vasoconstriction if the endothelium is removed or perturbed.",
"   </p>",
"   <p>",
"    NO has a number of other effects. It inhibits platelet adhesion and aggregation, an effect that may be synergistic with that of prostacyclin. NO blocks monocyte adhesion to the endothelium. Finally, it also reduces endotoxin- and cytokine-induced expression of tissue factor, thus modulating the prothrombotic potential of the endothelial cell.",
"   </p>",
"   <p>",
"    Paradoxical vasoconstriction of coronary arteries induced by acetylcholine was described in early and advanced human atherosclerosis. The current belief is that an abnormal vascular response to acetylcholine may represent a defect in EC vasodilator function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/23\">",
"     23",
"    </a>",
"    ], due, at least in part, to reduced EC production of nitric oxide (NO).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854585\">",
"    <span class=\"h2\">",
"     Leukocyte adhesion to endothelium",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pathophysiologic link has been made between inducible endothelial-leukocyte adhesion molecules and atherosclerosis (so-called athero-ELAMs) via the identification of an inducible endothelial cell-specific antigen that binds predominantly to monocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/24\">",
"     24",
"    </a>",
"    ]. Peptide sequencing revealed homology to the predicted sequence of human vascular cell adhesion molecule (VCAM)-1, which had been previously cloned as a cytokine-inducible protein in endothelial cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/25\">",
"     25",
"    </a>",
"    ]. Subsequently, VCAM-1 was localized to the endothelium overlying atherosclerotic lesions in a hyperlipidemic rabbit model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/24\">",
"     24",
"    </a>",
"    ] and was shown to be a risk factor for venous thrombosis in a kindred with protein C deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/26\">",
"     26",
"    </a>",
"    ]. These observations not only emphasized the role of endothelial dysfunction as a primary determinant of atherosclerosis, but also helped to refocus research and development on the inflammatory nature of this disease process.",
"   </p>",
"   <p>",
"    Currently, the term EC dysfunction may be broadly applied to states in which the EC phenotype, whether or not it meets the definition of activation, poses a net liability to the host. Examples include severe sepsis (see",
"    <a class=\"local\" href=\"#H1854605\">",
"     'Severe sepsis'",
"    </a>",
"    below), pulmonary hypertension, pathological angiogenesis, thrombotic thrombocytopenic purpura, hepatic venoocclusive disease, and sickle cell disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854645\">",
"    <span class=\"h1\">",
"     SEPSIS AS A MODEL ENDOTHELIOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sepsis is a common and often fatal disorder, in which changes in endothelial function play a central role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. In sepsis, the assault on the endothelium occurs on three separate fronts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pathogens may directly infect ECs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Components of the bacterial cell wall (eg, lipopolysaccharide (LPS)) may activate pattern recognition receptors on the surface of the EC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/31-34\">",
"       31-34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Host-derived products (eg, complement, cytokines, chemokines, serine proteases, fibrin, activated platelets and leukocytes, elevated glucose, reactive oxygen species or hypoxia-induced factors, and hemodynamic changes) may activate ECs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The endothelium responds to these stresses in ways that differ according to the nature of the pathogen, host genetics, underlying comorbidity, age, gender, and the location of the vascular bed. These responses may include structural changes, such as nuclear vacuolization, cytoplasmic swelling, cytoplasmic fragmentation, denudation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    detachment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/36\">",
"     36",
"    </a>",
"    ]. However, functional changes in the endothelium are even more common and include shifts in hemostatic balance, increased leukocyte adhesion and trafficking, altered vasomotor tone, loss of barrier function, and programmed cell death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854652\">",
"    <span class=\"h2\">",
"     Procoagulant properties",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory mediators may interact with ECs to induce a loss of the normal thromboresistant phenotype. In cultured endothelial cells, addition of bacterial lipopolysaccharide",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cytokines results in a series of procoagulant responses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/27,28\">",
"     27,28",
"    </a>",
"    ] including decreased synthesis of thrombomodulin (TM), tissue-type plasminogen activator and heparan sulfate, increased expression of tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1), and generation of procoagulant microparticles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In whole animal models of sepsis, however, the endothelium does not express detectable TF with the possible exception of the spleen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/38\">",
"     38",
"    </a>",
"    ]. Moreover, while the association of sepsis and decreased levels of TM has been confirmed in the skin vasculature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/39\">",
"     39",
"    </a>",
"    ], this phenomenon does not apply to all vascular beds. ECs of the blood brain barrier, for example, do not normally express TM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In vivo, properties of ECs that may contribute to the sepsis-associated procoagulant state include recruitment of platelets, monocytes, and neutrophils, all of which are capable of initiating or amplifying coagulation; cell surface translocation of anionic phospholipids that enhance the binding of coagulation complexes; increased exposure of subendothelium (eg, collagen, fibronectin, fibrinogen, von Willebrand factor), which may serve as attachment sites for platelets as ECs undergo apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/41,42\">",
"     41,42",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/9/29850?source=see_link&amp;anchor=H3#H3\">",
"     \"Congenital and acquired disorders of platelet function\", section on 'Platelet adherence'",
"    </a>",
"    ); and development of a low flow state, as a result of reduced cardiac output, vasoconstriction, or occlusive lesions, leading to reduced clearance of activated procoagulant serine proteases, thus promoting additional clotting.",
"   </p>",
"   <p>",
"    Evidence that increased endothelial cell anticoagulant activity can reverse the coagulopathy associated with LPS administration comes from a transgenic mouse model. When either the leech anticoagulant hirudin or human tissue factor pathway inhibitor (TFPI) was expressed on endothelial cells, monocytes, and platelets, widespread intravascular thrombosis, thrombocytopenia, and coagulopathy were inhibited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/43\">",
"     43",
"    </a>",
"    ]. While it does not describe a clinically-relevant approach, this study supports the postulate that modulation of endothelial cell properties can modify the clinical expression of endotoxemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854672\">",
"    <span class=\"h2\">",
"     Disseminated intravascular coagulopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtually all patients with severe sepsis have activation of the coagulation cascade. Initiation of clotting is thought to reflect expression of tissue factor on the surface of activated monocytes and macrophages, with subsequent induction of increased thrombin generation, and fibrin formation. In the extreme, this leads to depletion of coagulation factors, disseminated intravascular coagulation (DIC), and possible end-organ damage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/56/8073?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis and etiology of disseminated intravascular coagulation\", section on 'Pathogenesis of DIC'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The extent to which the above changes occur in the intact endothelium is not entirely clear. As with other properties of the endothelium, the hemostatic balance is differentially regulated among the various vascular beds. In a baboon sepsis model, for example, administration of lethal doses of E. coli resulted in increased fibrin deposition in the marginal zone and sinusoids of the spleen, hepatic sinusoids, glomeruli, and peritubular vessels of the kidney, but little or no fibrin in the portal vessels of the liver, cerebral cortex, skin, myocardium, or aorta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/38\">",
"     38",
"    </a>",
"    ]. These results, and similar data obtained in mouse models of sepsis, point to a predilection for organ-specific coagulation in sepsis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854692\">",
"    <span class=\"h2\">",
"     Genetic influences",
"    </span>",
"    &nbsp;&mdash;&nbsp;In mice with genetically-determined hypercoagulable states, sepsis results in a marked shift in hemostatic balance. For example, in mice that carry a thrombomodulin (TM) gene mutation, disruption of the TM-dependent activation of protein C via the administration of lipopolysaccharide (LPS) resulted in higher levels of fibrin deposition in the lung and kidney, but not the brain, compared with wild-type mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/44\">",
"     44",
"    </a>",
"    ]. In contrast, in heterozygous antithrombin-deficient mice, LPS challenge resulted in increased deposition of fibrin in the kidney, liver, and heart [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/45\">",
"     45",
"    </a>",
"    ]. These studies demonstrate the importance of underlying genetics in the sepsis phenotype. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/35/27194?source=see_link&amp;anchor=H20#H20\">",
"     \"Overview of hemostasis\", section on 'Activated protein C and protein S'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854712\">",
"    <span class=\"h2\">",
"     Pro-adhesive properties",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some endothelia, inflammatory mediators induce expression of adhesion molecules such as P-selectin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/46\">",
"     46",
"    </a>",
"    ], E-selectin, intercellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1. These alterations are particularly prominent on post-capillary venules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/47,48\">",
"     47,48",
"    </a>",
"    ], and result in increased rolling, adherence, and transmigration of leukocytes into underlying tissue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/54/36711?source=see_link\">",
"     \"Leukocyte-endothelial adhesion in the pathogenesis of inflammation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/41/17048?source=see_link&amp;anchor=H2#H2\">",
"     \"Determinants of neutrophil movement\", section on 'Neutrophil and endothelial cell interactions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Activated ECs also recruit increased numbers of platelets to the blood vessel wall. This process may contribute to vasoocclusive crises in patients with sickle cell disease by promoting adhesion of red cells. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14330?source=see_link&amp;anchor=H13#H13\">",
"     \"Vasoocclusion in sickle cell disease\", section on 'Blood vessels'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similarly, upregulation of platelet activating factor (PAF) receptors on chronically activated ECs may predispose patients with sickle cell disease to invasive pneumococcal infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/11/42170?source=see_link&amp;anchor=H21#H21\">",
"     \"Overview of the clinical manifestations of sickle cell disease\", section on 'Bacteremia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23143?source=see_link&amp;anchor=H6#H6\">",
"     \"Microbiology and pathogenesis of Streptococcus pneumoniae\", section on 'Invasion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854776\">",
"    <span class=\"h2\">",
"     Vasomotor properties",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasomotor tone is regulated through a combination of endothelial-dependent and -independent mechanisms. ECs produce vasoactive molecules that regulate arteriolar tone and contribute to blood pressure control. These factors include both vasodilators (eg, nitric oxide, prostacyclin) and vasoconstrictors (eg, endothelin, thromboxane A2, and platelet-activating factor). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/4/38982?source=see_link\">",
"     \"Inhaled nitric oxide in adults with pulmonary hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nitric oxide (NO) levels are elevated during sepsis and appear to play a complex role in the associated vascular pathology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. It has been suggested that red blood cells may directly mediate systemic vascular relaxation and hypotension in sepsis through NO-dependent mechanisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/29/23001?source=see_link&amp;anchor=H11#H11\">",
"     \"Structure and function of normal human hemoglobins\", section on 'Nitric oxide transport'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854796\">",
"    <span class=\"h2\">",
"     Increased permeability",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the intact vasculature, the endothelium forms a continuous, semipermeable barrier that varies in integrity in different vascular beds. A central feature of the endothelium in sepsis is its increased permeability and loss of barrier function, resulting in extravasation of circulating elements and tissue edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/52\">",
"     52",
"    </a>",
"    ]. Several agents contribute to this phenomenon:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Tumor necrosis factor (TNF)-alpha",
"      </strong>",
"      induces an increase in EC permeability both in vitro and in vivo.",
"     </li>",
"     <li>",
"      <strong>",
"       Thrombin",
"      </strong>",
"      increases EC permeability in vivo, while TNF-alpha and thrombin act synergistically to induce barrier dysfunction in vitro.",
"     </li>",
"     <li>",
"      <strong>",
"       Vascular endothelial growth factor (VEGF)",
"      </strong>",
"      , which is produced by several different cell types, acts on vascular endothelial cells to stimulate angiogenesis. VEGF induces EC proliferation, survival and directed migration, while it also increases vascular permeability. VEGF is 50,000 times more potent in inducing vascular leakage than histamine. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/60/1994?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of angiogenesis inhibitors\", section on 'Vascular endothelial growth factor'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854816\">",
"    <span class=\"h2\">",
"     EC apoptosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normally, less than 0.1 percent of all ECs are apoptotic. However, certain pathogens are capable of inducing EC apoptosis in vitro, and a host of mediators that are produced during sepsis may induce EC apoptosis. These include TNF-alpha, interleukin (IL)-1, interferon, oxygen-free radicals, and hypoxia. In addition, LPS-activated monocytes promote programmed cell death in ECs by a combination of TNF-alpha-dependent and -independent mechanisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EC apoptosis results in an accentuated proinflammatory response. Under in vitro conditions, apoptotic ECs mediate IL-1-dependent paracrine induction of ICAM-1 and VCAM-1, increased production of reactive oxygen species, increased procoagulant activity, decreased production of prostacyclin, and complement activation. ECs undergoing apoptosis also demonstrate increased binding to nonactivated platelets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a mouse model of endotoxemia, intraperitoneally delivered LPS resulted in widespread apoptosis of the endothelium, while in other studies, the intravenous administration of LPS induced EC apoptosis in the lung, but not the liver, again demonstrating organ-specific differences in endothelial response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854833\">",
"    <span class=\"h2\">",
"     Local versus systemic endothelial activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The innate host response evolved as a local mechanism to eradicate pathogens and necrotic tissue. The endothelium orchestrates this response by promoting the adhesion and transmigration of leukocytes, inducing thrombin generation and fibrin formation, altering local vasomotor tone, increasing vascular permeability, and triggering programmed cell death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/55\">",
"     55",
"    </a>",
"    ]. Normally, this is a compartmentalized process.",
"   </p>",
"   <p>",
"    However, when the host endothelial response becomes generalized, a dysregulated, inflammatory response ensues. Such widespread endothelial involvement may lead to the systemic inflammatory response syndrome (SIRS)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the multiple organ dysfunction syndrome (MODS). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=see_link\">",
"     \"Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis\"",
"    </a>",
"    .) Endothelial cell dysfunction in sepsis arises from an otherwise adaptive response. Therefore, targeting the host response too early may worsen patient outcome. Indeed, it is tempting to speculate that some of the failures in sepsis trials may be related to inadvertent interference with adaptive mechanisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854852\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF ENDOTHELIAL DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;One approach to studying EC function in vivo involves the use of strategically placed catheters that allow the examiner to sample blood from a specific vascular bed. Thus, coronary endothelial function can be evaluated in humans by selective infusion of acetylcholine into the epicardial coronary arteries, followed by measurement of vessel diameter and Doppler-derived velocity to calculate coronary blood flow. Using this technique, studies have revealed that coronary endothelial dysfunction is common in patients with coronary artery disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, newer proteomics techniques are likely to provide novel platforms (eg, protein-based chips) that will allow the practitioner to simultaneously monitor a panel of endothelial cell function biomarkers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=see_link&amp;anchor=H21#H21\">",
"     \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\", section on 'Proteomics'",
"    </a>",
"    .) For example, proteomics may be valuable in determining the presence or absence of specific complications (eg, graft versus host disease or sepsis) in patients undergoing hematopoietic cell transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/56\">",
"     56",
"    </a>",
"    ], in understanding changes in blood-brain barrier function in central nervous system disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/57\">",
"     57",
"    </a>",
"    ], or in assessing the pathologic mechanisms in stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/58\">",
"     58",
"    </a>",
"    ]. By extension, a more comprehensive and systematic analysis of pathological specimens (eg, skin biopsies) might provide even more robust data that reflect EC function.",
"   </p>",
"   <p>",
"    Imaging studies, such as Doppler measurements of blood flow, magnetic resonance angiography and CT scanning are widely available in clinical practice and should be applicable to the study of EC (dys)function in the near future. Molecular imaging, which combines the power of proteomics with advanced labeling techniques, is likely to revolutionize the diagnosis of endothelial-based disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854872\">",
"    <span class=\"h2\">",
"     Circulating endothelial cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Refined protocols to isolate and interrogate the phenotype of circulating endothelial cells (CEC) and their progenitors may yield insight into their function or their bed-of-origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/61-69\">",
"     61-69",
"    </a>",
"    ]. Thus, measurement of a panel of activation markers, rather than a single mediator, may yield previously unappreciated response patterns that will aid in diagnosis, monitoring,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment of vascular and coagulation disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/64,70,71\">",
"     64,70,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854880\">",
"    <span class=\"h2\">",
"     Microparticles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microparticles are vesicles of submicron size that are shed from plasma membranes in response to cell activation, injury, or apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/72\">",
"     72",
"    </a>",
"    ]. Although still in the development stage, enumeration of microparticles before and during treatment may prove helpful in revealing the degree of endothelial damage, as well as their response to treatment in various disorders involving microvascular injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/73-79\">",
"     73-79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/12/1224?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathogenesis of the hypercoagulable state associated with malignancy\", section on 'Tissue factor-bearing microparticles'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854887\">",
"    <span class=\"h1\">",
"     TREATMENT OF ENDOTHELIAL DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The endothelium is an attractive therapeutic target for several reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is strategically located between the circulating blood and every tissue, and is therefore rapidly and preferentially exposed to systemically administered agents.",
"     </li>",
"     <li>",
"      As a result of its high degree of plasticity, it should be amenable to therapeutic manipulation.",
"     </li>",
"     <li>",
"      Due to its close proximity to underlying tissues, the endothelium provides a direct line of communication to all organs of the body.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some examples of EC targeted therapies are outlined below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854605\">",
"    <span class=\"h2\">",
"     Severe sepsis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enormous resources have been expended on sepsis trials, with more than 10,000 patients enrolled in over 20 placebo-controlled, randomized, phase III clinical studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. In patients with severe sepsis, most of these therapies including anti-endotoxin, anti-cytokine, anti-prostaglandin, anti-bradykinin, anti-platelet activating factor strategies, antithrombin, and tissue factor pathway inhibitor have failed to reduce mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/80,82-84\">",
"     80,82-84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Five phase III clinical trials have demonstrated improved survival in critically ill patients or patients with severe sepsis. These include the use of low tidal volume ventilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/85\">",
"     85",
"    </a>",
"    ], low dose glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/86\">",
"     86",
"    </a>",
"    ], intensive insulin therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/87\">",
"     87",
"    </a>",
"    ], and early goal-directed therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/88\">",
"     88",
"    </a>",
"    ]. Though it is unclear as to the extent to which the endothelium mediates the survival benefit in these patient populations, each of these therapies may act, at least in part, by attenuating endothelial cell dysfunction. For example:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Low tidal volume ventilation may reduce barotrauma to the pulmonary endothelium.",
"     </li>",
"     <li>",
"      Activated protein C may inhibit endothelial cell apoptosis and activation.",
"     </li>",
"     <li>",
"      Low dose steroids may block pro-inflammatory transcriptional networks in the endothelium.",
"     </li>",
"     <li>",
"      Intensive insulin therapy may reduce the deleterious effects of hyperglycemia on ECs.",
"     </li>",
"     <li>",
"      Early goal-directed therapy should improve hemodynamic function and thus reduce EC shear stress.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854924\">",
"    <span class=\"h2\">",
"     Hemolytic anemia and nitric oxide depletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence suggests that nitric oxide (NO) metabolism is abnormal in patients with sickle cell disease, both at baseline and during acute illnesses, and may contribute to such complications as the acute chest syndrome, pulmonary hypertension, and priapism. This may be the result of increased plasma levels of cell-free hemoglobin secondary to hemolysis, which depletes NO. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27082?source=see_link&amp;anchor=H20#H20\">",
"     \"Pulmonary complications of sickle cell disease\", section on 'Mechanism'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23017?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis and management of priapism in sickle cell disease\", section on 'Nitric oxide pathway'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1652124075\">",
"    <span class=\"h2\">",
"     Acute chest syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhaled NO is under investigation as a potential therapy for acute chest syndrome (ACS) of sickle cell disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/89\">",
"     89",
"    </a>",
"    ]. NO may also act in part by reducing the adhesion of sickle erythrocytes to the pulmonary endothelium, an effect that may be mediated by downregulation of VCAM-1 expression in pulmonary ECs exposed to hypoxia. In anecdotal reports, inhaled NO has been effective in patients with severe ACS and larger trials are ongoing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27082?source=see_link&amp;anchor=H3#H3\">",
"     \"Pulmonary complications of sickle cell disease\", section on 'Acute chest syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854944\">",
"    <span class=\"h2\">",
"     Idiopathic pulmonary arterial hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/16/40200?source=see_link\">",
"     Bosentan",
"    </a>",
"    (Tracleer) is a novel, nonselective endothelin-receptor antagonist being studied as a treatment for both idiopathic pulmonary arterial hypertension (IPAH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/90\">",
"     90",
"    </a>",
"    ] and pulmonary hypertension associated with congenital heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/91\">",
"     91",
"    </a>",
"    ]. Animal models of pulmonary hypertension and the available experience in humans suggest that it is both safe and effective in this setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/24/35210?source=see_link\">",
"     \"Treatment of pulmonary hypertension in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1854964\">",
"    <span class=\"h2\">",
"     Macular degeneration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies now suggest that a variety of anti-angiogenic approaches directed at inhibiting the action of vascular endothelial growth factor (VEGF) may have a significant impact on the progression of",
"    <strong>",
"    </strong>",
"    age-related macular degeneration. Approaches currently under development include the anti-VEGF RNA aptamer (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/54/42851?source=see_link\">",
"     pegaptanib",
"    </a>",
"    ), anti-VEGF antibodies (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/40/33413?source=see_link\">",
"     ranibizumab",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    ), the VEGF receptor decoy (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/28/37312?source=see_link\">",
"     aflibercept",
"    </a>",
"    ), small interfering RNAs (bevasiranib and AGN211745), and tyrosine kinase inhibitors (vatalanib,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/2/1064?source=see_link\">",
"     pazopanib",
"    </a>",
"    , and others) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/10/36009/abstract/92\">",
"     92",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/52/6986?source=see_link&amp;anchor=H4#H4\">",
"     \"Age-related macular degeneration: Clinical presentation, etiology, and diagnosis\", section on 'Wet type AMD'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22755429\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelial cells (ECs) form the lining of all blood and lymphatic vessels within the vascular tree.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The endothelium mediates vasomotor tone, regulates cellular and nutrient trafficking, maintains blood fluidity, contributes to the local balance between pro- and anti-inflammatory mediators as well as procoagulant and anticoagulant activity, participates in generation of new blood vessels, interacts with circulating blood cells, and undergoes programmed cell death. Each of these activities is dynamically regulated in both space and time. (See",
"      <a class=\"local\" href=\"#H1854496\">",
"       'Endothelial heterogeneity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because endothelial cells receive cues from a wide variety of cells and tissues, they possess disparate properties that are specific to their local environment. This &ldquo;heterogeneity&rdquo; is a central feature of the endothelium, and includes variations in morphology, biosynthetic repertoire, and behavior. (See",
"      <a class=\"local\" href=\"#H1854541\">",
"       'Patterns of change in endothelial function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conditions in which endothelial function is disturbed include sepsis, disseminated intravascular coagulation, hemolytic anemia, acute chest syndrome, idiopathic pulmonary arterial hypertension, and macular degeneration. (See",
"      <a class=\"local\" href=\"#H1854190\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1854887\">",
"       'Treatment of endothelial disorders'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/1\">",
"      Jaffe EA. Cell biology of endothelial cells. Hum Pathol 1987; 18:234.",
"     </a>",
"    </li>",
"    <li>",
"     Cliff WJ. Blood Vessels, Cambridge University Press, New York 1976.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/3\">",
"      Gross PL, Aird WC. The endothelium and thrombosis. Semin Thromb Hemost 2000; 26:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/4\">",
"      Wagner DD, Frenette PS. The vessel wall and its interactions. Blood 2008; 111:5271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/5\">",
"      Yano K, Gale D, Massberg S, et al. Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium. Blood 2007; 109:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/6\">",
"      Aird WC. Spatial and temporal dynamics of the endothelium. J Thromb Haemost 2005; 3:1392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/7\">",
"      Nachman RL, Jaffe EA. Endothelial cell culture: beginnings of modern vascular biology. J Clin Invest 2004; 114:1037.",
"     </a>",
"    </li>",
"    <li>",
"     Hajjar KA. Vascular biology. In: Clinical Hematology, Young NS, Gerson SL, High KA (Eds), Mosby Elsevier, Philadelphia 2006. p.125.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/9\">",
"      Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91:3527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/10\">",
"      Aird WC. Endothelial cell heterogeneity. Crit Care Med 2003; 31:S221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/11\">",
"      Stevens T, Rosenberg R, Aird W, et al. NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am J Physiol Cell Physiol 2001; 281:C1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/12\">",
"      Aird WC. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med 2001; 29:S28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/13\">",
"      Oh P, Li Y, Yu J, et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004; 429:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/14\">",
"      Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996; 380:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/15\">",
"      Amatschek S, Kriehuber E, Bauer W, et al. Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. Blood 2007; 109:4777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/16\">",
"      Brooks EG, Trotman W, Wadsworth MP, et al. Valves of the deep venous system: an overlooked risk factor. Blood 2009; 114:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/17\">",
"      Solovey A, Kollander R, Shet A, et al. Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood 2004; 104:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/18\">",
"      Weninger W, Ulfman LH, Cheng G, et al. Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity 2000; 12:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/19\">",
"      Dekker RJ, van Soest S, Fontijn RD, et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kr&uuml;ppel-like factor (KLF2). Blood 2002; 100:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/20\">",
"      . The endothelial cell. Br Med J 1966; 2:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/21\">",
"      Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973; 180:1332.",
"     </a>",
"    </li>",
"    <li>",
"     Endothelial Dysfunction and the Pathogenesis of Atherosclerosis, Gimbrone MA Jr (Ed), Springer-Verlag, New York 1980.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/23\">",
"      Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/24\">",
"      Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/25\">",
"      Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/26\">",
"      Hasstedt SJ, Bezemer ID, Callas PW, et al. Cell adhesion molecule 1: a novel risk factor for venous thrombosis. Blood 2009; 114:3084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/27\">",
"      Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/28\">",
"      Lemichez E, Lecuit M, Nassif X, Bourdoulous S. Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat Rev Microbiol 2010; 8:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/29\">",
"      Lee WL, Slutsky AS. Sepsis and endothelial permeability. N Engl J Med 2010; 363:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/30\">",
"      Volk T, Kox WJ. Endothelium function in sepsis. Inflamm Res 2000; 49:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/31\">",
"      Faure E, Thomas L, Xu H, et al. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001; 166:2018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/32\">",
"      Henneke P, Golenbock DT. Innate immune recognition of lipopolysaccharide by endothelial cells. Crit Care Med 2002; 30:S207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/33\">",
"      Zhang FX, Kirschning CJ, Mancinelli R, et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 1999; 274:7611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/34\">",
"      Zhao B, Bowden RA, Stavchansky SA, Bowman PD. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. Am J Physiol Cell Physiol 2001; 281:C1587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/35\">",
"      Brown KA, Brain SD, Pearson JD, et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006; 368:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/36\">",
"      Vallet B, Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med 2001; 29:S36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/37\">",
"      Lacroix R, Sabatier F, Mialhe A, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood 2007; 110:2432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/38\">",
"      Drake TA, Cheng J, Chang A, Taylor FB Jr. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/39\">",
"      Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001; 345:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/40\">",
"      Ishii H, Salem HH, Bell CE, et al. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. Blood 1986; 67:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/41\">",
"      Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89:2429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/42\">",
"      Nachman RL, Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 2008; 359:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/43\">",
"      Chen D, Giannopoulos K, Shiels PG, et al. Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium. Blood 2004; 104:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/44\">",
"      Weiler H, Lindner V, Kerlin B, et al. Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol 2001; 21:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/45\">",
"      Yanada M, Kojima T, Ishiguro K, et al. Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice. Blood 2002; 99:2455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/46\">",
"      Andr&eacute; P. P-selectin in haemostasis. Br J Haematol 2004; 126:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/47\">",
"      Miyasaka M, Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004; 4:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/48\">",
"      Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002; 186:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/49\">",
"      Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/50\">",
"      Feihl F, Waeber B, Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol Ther 2001; 91:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/51\">",
"      Crawford JH, Chacko BK, Pruitt HM, et al. Transduction of NO-bioactivity by the red blood cell in sepsis: novel mechanisms of vasodilation during acute inflammatory disease. Blood 2004; 104:1375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/52\">",
"      Lee WL, Slutsky AS. Sepsis and endothelial permeability. N Engl J Med 2010; 363:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/53\">",
"      Lindner H, Holler E, Ertl B, et al. Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. Blood 1997; 89:1931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/54\">",
"      Bombeli T, Schwartz BR, Harlan JM. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 1999; 93:3831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/55\">",
"      McCuskey RS, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res 1996; 32:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/56\">",
"      Kaiser T, Kamal H, Rank A, et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 2004; 104:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/57\">",
"      Pottiez G, Flahaut C, Cecchelli R, Karamanos Y. Understanding the blood-brain barrier using gene and protein expression profiling technologies. Brain Res Rev 2009; 62:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/58\">",
"      Baird AE, Wright VL. Vascular biology: cellular and molecular profiling. Semin Neurol 2006; 26:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/59\">",
"      Mori N, Natarajan K, Chacko VP, et al. Choline phospholipid metabolites of human vascular endothelial cells altered by cyclooxygenase inhibition, growth factor depletion, and paracrine factors secreted by cancer cells. Mol Imaging 2003; 2:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/60\">",
"      Padera TP, Stoll BR, So PT, Jain RK. Conventional and high-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions. Mol Imaging 2002; 1:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/61\">",
"      Blann AD, Woywodt A, Bertolini F, et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005; 93:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/62\">",
"      Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005; 45:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/63\">",
"      Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109:1801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/64\">",
"      Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007; 137:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/65\">",
"      Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007; 110:2440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/66\">",
"      Ghosh A, Li W, Febbraio M, et al. Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. J Clin Invest 2008; 118:1934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/67\">",
"      Shantsila E, Blann AD, Lip GY. Circulating endothelial cells: from bench to clinical practice. J Thromb Haemost 2008; 6:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/68\">",
"      Mancuso P, Antoniotti P, Quarna J, et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res 2009; 15:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/69\">",
"      Tilki D, Hohn HP, Erg&uuml;n B, et al. Emerging biology of vascular wall progenitor cells in health and disease. Trends Mol Med 2009; 15:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/70\">",
"      K&ouml;rbling M, Reuben JM, Gao H, et al. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion 2006; 46:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/71\">",
"      Bidot L, Jy W, Bidot C Jr, et al. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost 2008; 6:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/72\">",
"      Chironi GN, Boulanger CM, Simon A, et al. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/73\">",
"      Erdbruegger U, Woywodt A, Kirsch T, et al. Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy. Am J Kidney Dis 2006; 48:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/74\">",
"      Woywodt A, Goldberg C, Kirsch T, et al. Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis. Ann Rheum Dis 2006; 65:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/75\">",
"      Solovey A, Lin Y, Browne P, et al. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337:1584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/76\">",
"      Mutin M, Canavy I, Blann A, et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999; 93:2951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/77\">",
"      Widemann A, Sabatier F, Arnaud L, et al. CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells. J Thromb Haemost 2008; 6:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/78\">",
"      Jourde-Chiche N, Dou L, Sabatier F, et al. Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients. J Thromb Haemost 2009; 7:1576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/79\">",
"      Georgescu A, Alexandru N, Popov D, et al. Chronic venous insufficiency is associated with elevated level of circulating microparticles. J Thromb Haemost 2009; 7:1566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/80\">",
"      Cohen J, Guyatt G, Bernard GR, et al. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001; 29:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/81\">",
"      Eichacker PQ, Parent C, Kalil A, et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 2002; 166:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/82\">",
"      Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286:1869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/83\">",
"      Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/84\">",
"      Abraham E, Reinhart K, Opal S, et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003; 290:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/85\">",
"      Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/86\">",
"      Annane D, S&eacute;bille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/87\">",
"      van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/88\">",
"      Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/89\">",
"      Sullivan KJ, Kissoon N, Gauger C. Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia. Pediatr Crit Care Med 2008; 9:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/90\">",
"      Barst RJ, Gibbs JS, Ghofrani HA, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/91\">",
"      Fine N, Dias B, Shoemaker G, Mehta S. Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review. Can J Cardiol 2009; 25:e63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/10/36009/abstract/92\">",
"      Mousa SA, Mousa SS. Current status of vascular endothelial growth factor inhibition in age-related macular degeneration. BioDrugs 2010; 24:183.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1330 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A20BFA4EA1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36009=[""].join("\n");
var outline_f35_10_36009=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22755429\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1854190\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1854489\">",
"      THE ENDOTHELIUM FROM BENCH TO BEDSIDE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1854496\">",
"      ENDOTHELIAL HETEROGENEITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854504\">",
"      Complex signaling patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854511\">",
"      Structural specializations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854527\">",
"      Temporal variations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854534\">",
"      Changing synthetic repertoires",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1854541\">",
"      PATTERNS OF CHANGE IN ENDOTHELIAL FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854549\">",
"      EC activation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854563\">",
"      EC dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854578\">",
"      Nitric oxide production",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854585\">",
"      Leukocyte adhesion to endothelium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1854645\">",
"      SEPSIS AS A MODEL ENDOTHELIOPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854652\">",
"      Procoagulant properties",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854672\">",
"      Disseminated intravascular coagulopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854692\">",
"      Genetic influences",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854712\">",
"      Pro-adhesive properties",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854776\">",
"      Vasomotor properties",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854796\">",
"      Increased permeability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854816\">",
"      EC apoptosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854833\">",
"      Local versus systemic endothelial activation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1854852\">",
"      DIAGNOSIS OF ENDOTHELIAL DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854872\">",
"      Circulating endothelial cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854880\">",
"      Microparticles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1854887\">",
"      TREATMENT OF ENDOTHELIAL DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854605\">",
"      Severe sepsis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854924\">",
"      Hemolytic anemia and nitric oxide depletion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1652124075\">",
"      Acute chest syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854944\">",
"      Idiopathic pulmonary arterial hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1854964\">",
"      Macular degeneration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22755429\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/15/29945?source=related_link\">",
"      Acute respiratory distress syndrome: Epidemiology; pathophysiology; pathology; and etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/52/6986?source=related_link\">",
"      Age-related macular degeneration: Clinical presentation, etiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36826?source=related_link\">",
"      Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/10/17576?source=related_link\">",
"      Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/32/39434?source=related_link\">",
"      Clinical variability in sickle cell anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/9/29850?source=related_link\">",
"      Congenital and acquired disorders of platelet function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/41/17048?source=related_link\">",
"      Determinants of neutrophil movement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23017?source=related_link\">",
"      Diagnosis and management of priapism in sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/39/23162?source=related_link\">",
"      Endothelial dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/4/38982?source=related_link\">",
"      Inhaled nitric oxide in adults with pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/54/36711?source=related_link\">",
"      Leukocyte-endothelial adhesion in the pathogenesis of inflammation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23143?source=related_link\">",
"      Microbiology and pathogenesis of Streptococcus pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/60/1994?source=related_link\">",
"      Overview of angiogenesis inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=related_link\">",
"      Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/35/27194?source=related_link\">",
"      Overview of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/11/42170?source=related_link\">",
"      Overview of the clinical manifestations of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/4/40009?source=related_link\">",
"      Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/56/8073?source=related_link\">",
"      Pathogenesis and etiology of disseminated intravascular coagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/45/30422?source=related_link\">",
"      Pathogenesis of diabetic retinopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/51/4920?source=related_link\">",
"      Pathogenesis of hantavirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=related_link\">",
"      Pathogenesis of preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/8/7304?source=related_link\">",
"      Pathogenesis of pulmonary hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/12/1224?source=related_link\">",
"      Pathogenesis of the hypercoagulable state associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5449?source=related_link\">",
"      Pathophysiology of sepsis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27082?source=related_link\">",
"      Pulmonary complications of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/41/17046?source=related_link\">",
"      Red blood cell mechanics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=related_link\">",
"      Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/29/23001?source=related_link\">",
"      Structure and function of normal human hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/39/28282?source=related_link\">",
"      Transfusion-related acute lung injury (TRALI)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/24/35210?source=related_link\">",
"      Treatment of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/40/28297?source=related_link\">",
"      Vascular endothelial function and fundamental mechanisms of fibrinolysis (thrombolysis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14330?source=related_link\">",
"      Vasoocclusion in sickle cell disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_10_36010="Pyogenic granuloma histology 2";
var content_f35_10_36010=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50978%7EDERM%2F71936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50978%7EDERM%2F71936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pyogenic granuloma from the neck of a 4-year-old boy. At higher power, the lesion consists of condensed small-caliber vessels with scattered red blood cells. The stroma is fibromyxoid with scattered inflammatory cells. Cytologic atypia and mitoses are not present, but can be seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Greg Hosler, MD, PhD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pyogenic granuloma from the neck of a 4-year-old boy. Histologic sections of skin show a polypoid lesion with an epidermal collarette. There is a vague lobular architecture to the vascular proliferation, and in this case, not much inflammation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Greg Hosler, MD, PhD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36010=[""].join("\n");
var outline_f35_10_36010=null;
var title_f35_10_36011="Lymph node staging EUS FNA";
var content_f35_10_36011=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Endoscopic ultrasound (EUS)-guided fine needle aspiration biopsy for lymph node staging in patients with esophageal carcinoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sensitivity*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specificity*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Accuracy*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reed, et al, 1999",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        72",
"       </td>",
"       <td>",
"        97",
"       </td>",
"       <td>",
"        86",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Giovannini, et al, 1999",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        97",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        97",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vazquez-Sequeiros, et al, 2001",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        93",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        93",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Catalano, et al, 1999",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         OVERALL",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         94",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         91",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         99",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         93",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Data shown represent percentages.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36011=[""].join("\n");
var outline_f35_10_36011=null;
var title_f35_10_36012="CHD benefit of lipid lowering";
var content_f35_10_36012=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55863&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55863&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Lipid lowering improves coronary outcome in patients with CHD",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Trial",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment regimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration, years",
"       </td>",
"       <td class=\"subtitle1\">",
"        CHD event reduction,",
"percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NHLBI, type II",
"       </td>",
"       <td>",
"        Diet plus resin",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        33",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        STARS",
"       </td>",
"       <td>",
"        Diet plus resin",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        89*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CLAS",
"       </td>",
"       <td>",
"        Diet plus resin plus",
"niacin",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CLAS II",
"       </td>",
"       <td>",
"        Diet plus resin plus niacin&nbsp;",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        43",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FATS",
"       </td>",
"       <td>",
"        Diet plus resin plus niacin",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"       <td>",
"        80*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FATS",
"       </td>",
"       <td>",
"        Diet",
"plus resin plus lovastatin",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"       <td>",
"        70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MARS",
"       </td>",
"       <td>",
"        Diet plus lovastatin",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        28",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CCAIT",
"       </td>",
"       <td>",
"        Diet plus lovastatin",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        SCRIP",
"       </td>",
"       <td>",
"        Diet plus drugs plus lovastatin (36%)",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        50*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PLAC I",
"       </td>",
"       <td>",
"        Diet plus pravastatin",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        62*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PLAC II",
"       </td>",
"       <td>",
"        Diet plus",
"pravastatin",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        REGRESS",
"       </td>",
"       <td>",
"        Diet plus pravastatin",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        42*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MAAS",
"       </td>",
"       <td>",
"        Diet plus pravastatin",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4S",
"       </td>",
"       <td>",
"        Diet plus",
"simvastatin",
"       </td>",
"       <td>",
"        5.4",
"       </td>",
"       <td>",
"        34*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *: statistically significant benefit.",
"     <br>",
"      Summary of lipid intervention trials performed in patients with hypercholesterolemia and coronary heart disease (CHD). Drug therapy lowered the coronary event rate in all studies, although not all of the changes were statistically significant.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36012=[""].join("\n");
var outline_f35_10_36012=null;
var title_f35_10_36013="Circumstances lead to homicide";
var content_f35_10_36013=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Known circumstances leading to homicide",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 364px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Conway, T, Arch Intern Med 1996; 156:951; with permission from the American Medical Association. Updated with information from: Crime in the United States 2008. U.S. Department of Justice Uniform Crime Reports.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36013=[""].join("\n");
var outline_f35_10_36013=null;
var title_f35_10_36014="Causes of myocarditis";
var content_f35_10_36014=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of myocarditis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Infectious causes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Viral",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Coxsackie B virus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Echovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Epstein-Barr virus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cytomegalovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Adenovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            HIV",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hepatitis B and C",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rubeola",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rubella",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Varicella",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Mumps",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Vaccinia (smallpox vaccine)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Variola",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Parvovirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Influenza A and B",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Herpesvirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Poliomyelitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rabies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Arborvirus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Dengue",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Yellow fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Bacterial",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Diphtheria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Tuberculosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Salmonella",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Staphylococcal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Gonococcal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Clostridial",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Brucellosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Psittacosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Tetanus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Tularemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Streptococcal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Legionella",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Meningococcal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Haemophilus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pneumococcal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cholera",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Chlamydia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Mycoplasma",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Infectious causes (cont.)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Spirochetal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Syphilis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Leptospirosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Relapsing fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Lyme disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Mycotic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Candidiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Histoplasmosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sporotrichosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Coccidiomycosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Aspergillosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Blastomycosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cryptococcosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Actinomyocosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Mucormycosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Nocardia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Strongyloidiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Rickettsial",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Typhus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Q fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rocky mountain spotted fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Protozoal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Chagas' disease (South American trypanosomiasis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sleeping sickness (African trypanosomiasis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Toxoplasmosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Malaria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Leishmaniasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Amebiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Helminthic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Trichinosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Echinococcosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Schistosomiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ascariasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Filariasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Paragonimiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Strongyloidiasis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Noninfectious causes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Cardiotoxins",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Catecholamines",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Anthracyclines",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cyclophosphamide",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cocaine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Heavy metals (copper, lead, iron)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Alcohol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Arsenic",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Carbon monoxide",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Methysergide",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Hypersensitivity reactions",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Antibiotics (penicillins, cephalosporins, sulfonamides)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Diuretics (thiazide, loop)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Dobutamine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Lithium",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Tetanus toxoid",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Clozapine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Methyldopa",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Insect bites (bee, wasp, spider, scorpion)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Snake bites",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Systemic disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Collagen-vascular diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Celiac disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Kawasaki disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hypereosinophilia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Granulomatosis with polyangiitis (Wegener's)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Thyrotoxicosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Inflammatory bowel disease (Crohn's disease, ulcerative colitis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Radiation",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36014=[""].join("\n");
var outline_f35_10_36014=null;
var title_f35_10_36015="Bulky foot compression dressing";
var content_f35_10_36015=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F55324&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F55324&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Bulky foot compression dressing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The bulky foot compression dressing is used to treat calcaneal fractures and foot injuries. Sheet wadding in several layers is applied after cotton fluffs are placed between the toes, and elastic bandage is used to wrap the foot. The elastic wrap should be looser around the leg than the ankle, providing a pressure gradient to facilitate drainage for edema.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_10_36015=[""].join("\n");
var outline_f35_10_36015=null;
